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Abstract: 
Polyglutamine is a naturally occurring peptide found within several proteins in 
neuronal cells of the brain, and its aggregation has been implicated in several 
neurodegenerative diseases, including Huntington's disease. The resulting aggregates 
have been demonstrated to possess ~-sheet structure, and aggregation has been shown to 
start with a single misfolded peptide. The current project sought to computationally 
examine the structural tendencies of three mutant poly glutamine peptides that were 
studied experimentally, and found to aggregate with varying efficiencies. Low-energy 
structures were generated for each peptide by simulated annealing, and were analyzed 
quantitatively by various geometry- and energy-based methods. According to the results, 
the experimentally-observed inhibition of aggregation appears to be due to localized 
conformational restraint placed on the peptide backbone by inserted prolines, which in 
tum confines the peptide to native coil structure, discouraging transition towards the ~­
sheet structure required for aggregation. Such knowledge could prove quite useful to the 
design of future treatments for Huntington's and other related diseases. 
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1. INTRODUCTION 
1.1. Reason for Studying Polyglutamine: Huntington's Disease and the 
Huntingtin Protein 
1 
Huntington's disease (HD) is a hereditary neurodegenerative disease of the brain. 
It is characterized by behaviour problems, personality changes and dementia that 
typically begin in midadulthood, and results in death within a few years of onset. 1,2,3 The 
disease is caused by an abnormal expansion of CAG trinucleotide repeats, which encode 
the amino acid L-glutamine, within exon 1 of the IT-J5 gene. This in turn results in 
production of huntingtin protein containing an abnormally long sequence of L-glutamine 
amino acid residues, known as an expanded poly-L-glutamine sequence, near its amino 
terminus. 1,2,4,5 
Huntingtin is a protein that is normally found in healthy neuronal cells, although 
its normal biological function remains unclear. Some studies have argued that huntingtin 
is important in the uptake and utilization of iron within neurons, assisting in the 
conversion of iron to a bioavailable form. 6,7 Others suggest that huntingtin is involved in 
intracellular transport, in conjunction with other known transport proteins. 8,9 More 
notably, a study of mice lacking the gene for huntingtin has demonstrated that huntingtin 
is important in proper embryonic development. 1o Nevertheless, abnormal expansion of 
the poly-L-glutamine region of huntingtin leads to a characteristic formation of insoluble 
proteinaceous plaques in neuronal cells, which is believed to play a key role in the 
neuronal cell death associated with HD. While shorter poly-L-glutamine sequences are 
not associated with occurrence of the disease, HD almost invariably occurs when the 
poly-L-glutamine sequence exceeds 37 residues in length, with progressively longer 
sequences resulting in onset ofthe disease at an exponentially earlier age. 1,2,4,5,1 1 
2 
Poly-L-glutamine (polyQ) is a naturally occurring polypeptide found in a number 
of different proteins, and polyQ sequences exceeding a certain critical length have been 
implicated in several neurodegenerative diseases, including HD?,12,13 The presence of 
such extended polyQ sequences leads to conformational changes within the protein, and 
subsequent protein aggregation via polyQ sequence association (see Figure 1), ultimately 
resulting in formation of the disease-associated protein plaques.1,3,12,13,14,15 However, it 
should be noted that some studies have found the soluble oligomers of abnormally-folded 
polyQ to cause cell death even in the absence of larger aggregates, suggesting the 
individual oligomers themselves to be toxic to neuronal cells. 1,16,17 In either case, toxicity 
may result from disruptive interactions with, or intra-aggregate incorporation of, other 
cellular proteins or disruption of the cell membrane. 18,19,20,21 
Recently, it has been suggested that the polyQ sequence of huntingtin may serve 
as an osmotically-stable glutamine reservoir, which can be cleaved from huntingtin and 
degraded to provide a source of glutamine, and its metabolite glutamate, when the levels 
of these vital amino acids within the host neuronal cells become too low.22 Expansion of 
the polyQ sequence may gradually overwhelm the normal degradation mechanism with 
age, resulting in the release of intact polyQ chains which could then assemble into 
oligomers and larger aggregates. Indeed, others have suggested that the polyQ chain is 
cleaved from huntingtin prior to aggregation, I ,3,23 and several in vitro and in vivo 
aggregation studies of synthetic polyQ peptides have demonstrated a high capacity of 
isolated polyQ for aggregation, thus supporting the idea that polyQ forms aggregates 
when isolated from its host protein?4,25,26 As a result of such abnormal polyQ processing, 
the supply of glutamine and glutamate provided by the polyQ chains would be 
3 
progressively cut off, thus potentially leading to a harmful deficiency of glutamine and 
glutamate contributing to neuronal cell death.22 
Native 
monomer 
Soluble ~-sheet 
monomer 
.... 
fibrils 
Figure 1: General schematic inferred for the aggregation of polyglutamine-containing 
proteins. 16 A conformational shift within the native structure converts the polyglutamine 
chain (highlighted in black) to an abnormal ~-sheet structure, which then self-associates 
into ~-sheet oligomers, fibrillar aggregates, and eventually, plaques. 
Whatever the mechanism of toxicity, it is clear that aggregation of abnormally-
folded polyQ is somehow associated with the neuronal cell death of HD. Indeed, Poirier 
et al. (2005)27 found that huntingtin amino-terminal fragments capable of aggregation 
within mammalian neuronal cells (via polyQ association) induced visible cytotoxicity 
upon aggregation, while huntingtin amino-terminal fragments that failed to form visible 
aggregates induced no such cytotoxicity. In addition, in vitro and in vivo aggregation 
studies of polyQ performed by Scherzinger et al. (1997),3 Ignatova and Gierasch (2006i8 
and otherss, ls ,29 have indicated that a minimum polyQ chain length of approximately 37-
40 residues is required for abnormal polyQ folding and aggregation to occur 
spontaneously under normal physiological conditions, in agreement with clinical data 
indicating the occurrence of HD at such polyQ chain lengths. Finally, the rate of 
4 
aggregation increases as polyQ chain length increases, which may explain the decrease in 
the age of HD onset that occurs as the polyQ sequence increases in length?5,28 
1.2. Polyglutamine Structure and Aggregation 
Polyglutamine (polyQ) chains have been shown by a number of experimental 
studies to assemble into highly ordered and stable fibrillar aggregates, following 
transition from harmless native states to abnormal molecular structures (as outlined in 
Figure 1), The native state of polyQ is believed to be a coil structure, as suggested from 
circular dichroism and NMR experiments on polyQ-containing proteins, although the true 
native structure of polyQ in huntingtin is not known with certainty?1 ,25,30 However, X-
ray diffraction, electron microscopy, circular dichroism and solid-state NMR data have 
indicated that when polyQ aggregates, it forms linear, unbranched fibrils with a 
characteristic "cross-~" structure.3,15,18,24,31,32,33,34,35,36 This structure consists of ~-sheets 
oriented parallel to the fibril axis, with their ~-strands nearly perpendicular to the axis (as 
outlined in Figure 2). 
In particular, X-ray diffraction patterns for polyQ aggregates have invariably 
demonstrated a characteristic 4.8 A meridional reflection, indicating the presence of 
hydrogen-bonded ~-strands oriented perpendicular to the fibril axis. Circular dichroism 
data and internuclear couplings observed in NMR data have also confirmed the presence 
of ~-strand-containing structures within the aggregates, and electron microscopy 
observations have highlighted the linear nature of the fibrils . Also, the binding of Congo 
red dye to polyQ aggregates produces an apple-green birefringence upon examination 
with polarized light microscopy, indicating an alignment of the dye molecules along 
5 
linear, regular fibril structures.37,38,39,40 Illustrations of example cross-~ structures for an 
antiparallel ~-sheet and a parallel ~-helix are provided in Figure 2. 
(a) 
('--....... __ ... _ ....... -----., } 4.8 A 
~ 
(b) 
Figure 2: Schematic illustrations of cross-~ structures for (a) an antiparallel ~-sheet, and 
(b) a parallel ~-helix. All ~-strands are illustrated as red arrows, the direction of the fibril 
axis is indicated by a blue arrow, and the 4.8 A spacing between hydrogen-bonded ~­
strands (corresponding to the meridional 4.8 A X-ray diffraction feature) is labelled. 
Within the inferred ~-sheet structure, neighbouring ~-strands are bound to each 
other by stacks of hydrogen bond interactions between both the peptide bond functional 
groups of the polyQ backbone, and the amide groups of the glutamine side chains (see 
Figure 3). These hydrogen-bond stacks span the entire length of the fibril, forming a so-
called "polar zipper" which is crucial to fibril formation and stabilization?4,34,4] ,42 Such 
participation of the side chains in hydrogen bonding was confirmed by NMR data, in 
which distinct l3C and ]5N couplings indicated the presence of an ordered arrangement of 
the side chain amides. 43 ,44 In addition, mutation studies of fibril-forming proteins, 
including huntingtin, have demonstrated that amino acid substitutions within the fibril-
forming segments of these proteins typically diminished aggregation, highlighting the 
importance of the side chains to aggregate assembly.37,45 Once formed, the polyQ fibrils 
can then associate with each other via hydrophobic and/or electrostatic interactions to 
form larger fibres, and eventually, the proteinaceous plaques associated with RD. 
6 
Figure 3: The polar zipper of polyglutamine ~-sheet structures.35 Backbone hydrogen 
bonds are highlighted as yellow and red bars, and side chain hydrogen bonds are 
highlighted in pink and cyan. The individual ~-strands are shown in side view, and 
illustrated using the standard atomic colour scheme: gray = carbon; white = hydrogen; 
blue = nitrogen; red = oxygen. 
It has also been demonstrated that polyQ assembles into fibrils by means of a 
cooperative nucleation-growth mechanism. 13,14,21 ,23 ,25,28.29,34, 46 In this mechanism, a 
critical nucleus for aggregation, consisting of a small section of the ~-sheet fibril 
structure, is first formed from a small number of abnormally-folded polyQ chains (in a 
process called nucleation). Then, the aggregate grows quickly into a fibril as additional 
polyQ chains are added onto the initial nucleus, which serves as a template for misfolding 
and binding of the additional polyQ chains. This mechanism was supported by the 
b . fl' d . . k" d' 1421 25293346 D' h 1 o servatIOn 0 a ag peno m aggregatIOn metlcs stu les. ' , , " unng t e ag 
period, the nucleus would assemble slowly due to an energetically unfavourable loss of 
entropy as the polyQ structure becomes more ordered, as well as kinetic barriers in the 
transition to the required ~-sheet structure. After the lag phase, however, aggregation 
would be more rapid due to favourable enthalpy changes, which result from the 
formation of progressively more extensive polar-zipper hydrogen bonding as more polyQ 
chains are added to the developing fibril. 
7 
Furthermore, Chen et al. (2002)25 and Thakur and Wetzel (2002)26 both deduced 
from measured aggregation kinetic parameters that a single polyQ chain serves as the 
critical nucleus for fibril formation. Additionally, Bhattacharyya et al. (2005)47 deduced 
a free energy of nucleation of approximately 12.2 kcallmol from the measured 
equilibrium constant for nucleation. Thus, nucleation likely involves an unfavourable 
structure transition within the polyQ monomer, during which the monomer assembles 
into a ~-sheet structure that acts as the required nucleus for further aggregation. 
1.3. Proposed Structural Models for Polyglutamine Aggregates 
Various models demonstrating cross-~ structure (see Section 1.2) have been 
proposed for the ~-sheet structure of polyQ and its aggregates, and a controversy still 
exists as to which model is correct. II A major reason for such controversy is the 
insolubility of polyQ in many experimental solvents, which makes structural examination 
by standard, high-resolution methods (such as X-ray crystallography and solution NMR) 
quite difficult. 13,45 Consequently, there has been a great deal of reliance on theoretical 
studies, and on lower-resolution experimental methods such as X-ray fibril diffraction 
and solid-state NMR, with rather sparse experimental evidence of higher-resolution 
structure. In addition, variations in fibril packing within polyQ aggregates could 
influence the observed X-ray and NMR results, leading to variations between the results 
- and subsequent interpretations - of different experiments. Therefore, verification of 
anyone proposed structural model, and rejection of the others, with certainty has proven 
infeasible at this point in time?3,48 
PolyQ peptides have been reported as being able to form a number of abnormal 
structures. For instance, a ,number of studies have reported the presence of various 
8 
intermediate speCIes that anse during the aggregation process, rangmg from small 
oligomers to spherical and amorphous aggregates, although some of these intermediates 
may be off-pathway polyQ assemblies that compete with the main fibril formation 
pathway.4,20,23,49 In addition, some theoretical I 1,50 and experimentaI4,51 ,52,53 studies have 
suggested that polyQ peptides can assemble into annular structures. In this type of 
structure, shorter peptides form tube-like assemblies that resemble ~-barrels, with their 
polyQ chains inclined at approximately 45° to the tube axis. Longer peptides, on the 
other hand, assemble into large ring-like structures that resemble disordered ~-helices, 
with their polyQ chains nearly perpendicular to the ring axis. For instance, atomic force 
microscopy work by Wacker et al. (2004)4 found that huntingtin containing an expanded 
polyQ sequence could form small annular structures, and X-ray diffraction work by Elam 
et al. (2003)53 found that the polyQ segment of mutant SOD! also formed annular 
structures. To date, however, two predominant classes of underlying structure have been 
proposed for polyQ aggregates: ribbon-like fibrils, and ~-helix-based fibrils. 54 
1. 3.1. Ribbon-like Polyglutamine Fibrils 
Some researchers have argued that polyQ chains may form aggregates similar to 
those formed by the proteins associated with Alzheimer'S, Parkinson's, and several other 
so-called "amyloid diseases". 15,31,35,36,37,42,55 In this model, the chains first assemble side-
by-side into long ~-sheets stabilized by polar-zipper hydrogen bonding.23,31 ,32,37,42,49,56 
Two or more ~-sheets then stack together, with the meeting side chains of each pair of 
adjacent sheets interdigitating to form "steric zippers" between the sheets (see Figure 4). 
This gives rise to a ribbon-like fibril, which can then associate with others to form larger 
aggregates. Within such aggregates, the constituent polyQ chains could potentially form 
9 
one of a number of possible subunit structures, including extended B-strands, B-hairpins, 
or compact B-sheets (see Figure 5).54 However, compact B-sheets would be more likely 
for long polyQ chains, as folding of the chain would more effectively constrain the 
ribbon width to within the fibril widths that have been observed by electron 
microscopy. 57 In addition, the B-sheet structure within the fibrils often possesses a left-
handed twist, due to the left-handed chirality of the constituent amino acid residues, 
resulting in fibrils with a twisted or helical ribbon structure. 32,33,49 
(a) (b) 
Figure 4: Ribbon structure model of polyglutamine aggregates, composed of stacked B-
sheets formed by polyglutamine chains.35 A segment of a fibril composed of two stacked 
B-sheets is shown: (a) end view of fibril ; (b) top view of fibril. For clarity, the direction 
of the fibril axis is indicated by a green arrow (illustrated pointing into the page as a 
circled "X", and pointing along the page as a standard arrow). Also, one B-sheet is 
highlighted in yellow to distinguish the two sheets from each other. The other sheet is 
illustrated using the standard atomic colour scheme: gray = carbon; white = hydrogen; 
blue = nitrogen; red = oxygen. Note the interdigitation of side chains from adjacent B-
sheets, which is clearly visible in the fibril end view, and the ridges of hydrogen-bonded 
side chains (characteristic of a polar zipper), which are clearly visible in the fibril top 
VIew. 
(a) 
t~oo=occooococaX~:.CN 
(c) 
10 
(b) 
(d) 
Figure 5: Examples of possible underlying ~-sheet structures within ribbon-like fibrils of 
polyglutamine: (a) antiparallel or (b) parallel arrangements of extended ~-strands; (c) ~­
hairpins; (d) compact ~-sheets. 54 The amino-terminus and carboxy-terminus are 
indicated by "N" and "C", respectively. 
Particularly notable evidence for ribbon-like fibril structure comes from a number 
of recent X-ray diffraction studies, including those performed by Sikorski and Atkins 
(2005),35 Sharma et al. (2005)36 and Sawaya et at. (2007).37 In these studies, the 
observed polyQ X-ray diffraction patterns exhibited a strong 4.8 A meridional reflection 
indicative of hydrogen-bonded ~-strands, as well as an appreciable 8-11 A equatorial 
reflection indicative of ~-sheet stacking. Thus, the underlying aggregate structure was 
determined to be a cross-~ structure composed of stacked ~-sheets: a ribbon-like fibril 
structure. 
In addition, a number of computational studies on this polyQ model have 
suggested that this may indeed be a plausible structure for polyQ aggregates. In 
particular, Bellesia and Shea (2007)31 and Marchut and Hall (2007)11 observed the 
spontaneous formation of ~-sheet structures in coarse-grained MD simulations of systems 
of polyQ chains. Marchut and Hall (2007) even observed the formation of a number of 
possible ~-hairpin and compact ~-sheet structures, with longer polyQ chains exhibiting a 
tendency towards compact ~-sheets, as expected from experiment. Therefore, a ribbon-
11 
like fibril structure is a valid model for polyQ aggregates, with the extended polyQ chains 
likely forming compact ~-sheet subunits. 
1.3.2. The Perutz Model of Polyglutamine: fJ-Helix-Based Fibrils 
Another notable model for huntingtin polyQ has been a ~-helical structure, which 
was originally proposed by Perutz et al. (2002),34 and supported by a number of other 
studies. 16,58,59 In the Perutz model for polyQ, sufficiently long polyQ chains fold into a ~-
helix structure that forms the underlying subunit of polyQ fibrils. 34,48 This structure 
consists of a chain of amino acid residues in ~-strand-like conformations, coiled to form a 
wide left-handed helix in which adjacent helical turns are hydrogen-bonded to each other, 
in a configuration similar to that of a parallel ~-sheet (see Figure 6). The resulting helix 
has 20 residues per tum, a pitch of approximately 4.8 A,60 and amino acid side chains that 
alternate between facing the interior and facing the exterior of the helix. 
(a) (b) 
Figure 6: The ~-helical structure model of polyglutamine, as deduced by Perutz et al. 
(2002)?4,54 (a) Stick model representation, with the peptide backbone shown in orange, 
the glutamine side chains in gray, and hydrogen bonds as dotted lines. (b) Ribbon model 
representation, with the amino-terminus and carboxy-terminus indicated by "N" and "C", 
respectively. 
To deduce the structure of polyQ, Perutz et al. (2002)34 examined X-ray 
diffraction, electron microscopy, and other experimental data for free poly-L-glutamine 
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and the exon-l peptide of human huntingtin. They determined that the only possible 
structures which could account for all of the data, as well as intramolecular steric 
considerations, were helical ~-sheet structures consisting of parallel ~-strands wound 
around a central axis, with 20 residues per tum. In particular, the X-ray diffraction data 
exhibited the strong 4.8 A meridional reflection typical of a cross-~ structure (described 
in Section 1.2), but the 8-11 A equatorial reflection that would otherwise indicate the 
presence of stacked ~-sheets was absent or greatly diminished. Therefore, Perutz 
concluded that rather than forming stacked ~-sheets, the polyQ must adopt a coiled ~­
sheet structure, with its ~-strands nearly perpendicular to the coil axis: a ~-helix. 
The Perutz model also provides a possible explanation for the observed polyQ 
critical chain length of 37-40 residues that is required for aggregation. According to 
Perutz et al. (2002), the first sufficiently stable structure for a ~-helical polyQ aggregate 
nucleus would occur when the chain reached 37-40 residues in length. At this length, the 
polyQ would form approximately two helical turns, thus permitting stabilization by 
polar-zipper hydrogen bonding around the entire circumference of the helix. However, if 
the chain was only 20 or 30 residues in length, the lesser extent of hydrogen bonding 
would be insufficient to properly stabilize the ~-helical structure around its entire 
circumference, thus discouraging its formation. Once the nucleus has formed, outward 
growth of the developing fibril would occur primarily at its ends, with polyQ monomers 
stacking onto each other to form a fibril with continuous ~-helix structure along its entire 
length. The fibrils could then associate with each other over time, via a combination of 
hydrophobic and electrostatic interactions, to give rise to larger aggregates. 
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Indeed, by performing molecular dynamics simulations of several proposed 
structures for polyQ, including several ~-hairpin and ~-sheet structures, Elliot et al. 
(2006)13 suggested that the most reasonable structure for polyQ may be a Perutz ~-helix, 
based on the fact that only the Perutz helix demonstrated a systematic increase in stability 
with polyQ chain length, as expected from experiment. In addition, Marchut and Hall 
(2007) 11 occasionally observed the spontaneous formation of ~-helix structures in their 
coarse-grained MD simulations of 48-residue polyQ chains. Finally, root-mean-square 
deviations (RMSDs) from the Perutz helix structure during the polyQ simulations 
performed by Ogawa et al. (2007) 12 have demonstrated an increase in helical structure 
stability with addition of polyQ chains, which is consistent with the idea that the 
aggregation mechanism is cooperative in nature. 
It should be noted, though, that simulation studies by Khare et al. (2005)41 and 
Ogawa et al. (2007)12 have suggested that a more stable configuration of ~-sheet 
hydrogen bonds would be formed within the ~-helix if it had 18.5 residues per tum, rather 
than 20 residues per tum. Also, the findings of Marchut and Hall (2007), II Ogawa et al. 
(2007)12 and Elliot et al. (2006)13 seem to suggest that the polyQ monomer would 
actually adopt a less regular helix structure than that originally proposed by Perutz et al. 
(2002).34 
1.4. Proposed Strand-Turn-Strand Structural Motif and Implications for 
Polyglutamine Structure 
A recent mutation study of polyQ peptides by Thakur and Wetzel (2002)26 has 
provided notable insight into the underlying ~-sheet structure of polyQ aggregates. The 
authors hypothesized that polyQ monomers form antiparallel ~-sheets, which in tum 
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make up the underlying structure of polyQ aggregates. Accordingly, they examined the 
aggregation kinetics of a synthetic polyQ peptide containing 45 glutamine residues, as 
well as similar-sized peptides containing four intervals of 7-10 glutamine residues 
separated by proline-glycine pairs, which are known to promote ~-turn formation. 
Measurement of the concentration of soluble peptide over the course of several hundred 
hours in vitro revealed that the proline-glycine mutants containing intervals of nine 
(PGQ9 mutant) or ten (PGQIO mutant) glutamines aggregated at a rate similar to that of 
the 45-glutamine peptide (see Figure 7). However, the mutant peptides containing 
intervals of only seven (PGQ7 mutant) or eight (PGQ8 mutant) glutamines aggregated 
much more slowly than the 45-glutamine peptide. In addition, a modified PGQ9 peptide 
containing D-proline-L-glycine pairs, which induce ~-turns even more strongly than 
normal L-proline-L-glycine pairs, aggregated more efficiently than did PGQ9. Finally, 
antibody binding and electron microscopy assays of the resulting aggregates revealed that 
they all assumed very similar fibril structures, and heterologous seeding assays revealed 
that the peptides efficiently seeded each other's aggregation, further supporting the idea 
of compatible structures. Therefore, the authors determined that the individual chains 
within polyQ aggregates must adopt a structure composed of alternating ~-turn and 
extended ~-strand elements, since the tum-inducing proline-glycine pairs were so readily 
accommodated upon aggregation, and that uninterrupted intervals of at least nine 
glutamine residues are required for efficient formation of ~-sheet structure. 
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Figure 7: Aggregation kinetics of Q45 (0), PGQ7 (.), PGQ8 ( .. ), PGQ9 (.), and PGQ 10 
(_).26 Plots of soluble peptide concentration versus time are shown, and a drop in peptide 
concentration over time is indicative of aggregation. 
Based on this finding, the authors concluded that the polyQ chains formed four-
stranded antiparallel ~-sheet structures (see Figure 8a), which would form the basis of 
polyQ aggregates containing ribbon-like fibrils (see Section 1.3.1). Accordingly, they 
suggested that the mutant peptides folded in such a way that the proline-glycine pairs 
were incorporated into the ~-turns, with which these residue pairs would be structurally 
compatible, while the four glutamine intervals formed the extended ~-strands (see Figure 
8b). Indeed, discontinuous molecular dynamics (DMD) simulations of PGQ9 performed 
by Khare et al. (2005)41 indicated a preference of this peptide for antiparallel ~-sheet 
structure over ~-helix structure, thus supporting Thakur and Wetzel's conclusion about 
the aggregate structure of the mutant peptides. 
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Figure 8: Schematic diagrams of antiparallel p-sheet structures deduced by Thakur and 
Wetzel (2002) for (a) a 45-glutamine peptide, and (b) the PGQ9 mutant peptide.26 The 
four-residue p-tums are highlighted in red, and the intervening extended p-strands are 
highlighted in black. All peptides that were examined contained terminal pairs of lysine 
residues, to ensure monomer solubility in the aqueous experimental solutions. 
Additionally, Thakur and Wetzel (2002) examined the aggregation behaviour of a 
number of mutant variants of the PGQ9 peptide (see Table 1), in which the central residue 
of one or two of the four polyglutamine segments was substituted with an additional 
proline residue. This further analysis was done to confirm whether the four 
polyglutamine segments of PGQ9 actually form extended p-strands, based on the logic 
that proline insertions into the middle of the p-strand-forming elements of PGQ9 should 
inhibit its aggregation. Indeed, it was found that such mutations completely abolished 
aggregation (see Figure 9). The only exception was the PGQ9 variant containing a single 
additional proline in the first glutamine interval (i.e. PGQ9(pl)), for which aggregation 
was slowed rather than completely abolished. Based on these results, the authors 
confirmed that the four polyglutamine segments of PGQ9 form extended p-strands, and 
determined that proline insertions into a polyQ chain effectively inhibit aggregation when 
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the prolines are placed into reglOns of the polyQ that are predisposed by existing 
mutations to form extended ~-strand elements of the aggregate structure. 26 
Table 1: PGQ9-Based Mutant Peptides Examined by Thakur and Wetzel (2002)26 
Mutant Peptide Amino Acid Sequencea 
PGQ9 K2-Q9-PG-Q9-PG-Q9-PG-Q9-K2 
PGQ9(pl) K2-Q4PQ4-PG-Q9-PG-Q9-PG-Q9-K2 
PGQ9(pL) K2-Q9-PG-Q4PQ4-PG-Q9-PG-Q9-K2 
PGQ9(p 1,L) K2-Q4PQ4-PG-Q4PQ4-PG-Q9-PG-Q9-K2 
PGQ9(pL,4) K2-Q9-PG-Q4PQ4-PG-Q9-PG-Q4PQ4-K2 
PGQ9(p2,J) Kr Q9-PG-Q4PQ4-PG-Q4PQ4-PG-Q9-K2 
PGQ9(pJ,4) K2-Q9-PG-Q9-PG-Q4PQ4-PG-Q4PQ4-K2 
aAll peptldes that were exammed contamed termmal pairs of lysine residues, to ensure 
monomer solubility in the aqueous experimental solutions. The four polyglutamine 
segments of each peptide are highlighted in bold. 
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Figure 9: Aggregation kinetics of PGQ9 (.), PGQ9(p l) (.), PGQ9(p2) (0), PGQ9(p l,2) (.), 
PGQ9(p2,4) (fl), PGQ9(p2,3) (.), and PGQ9(p3,4) (O)?6 Plots of soluble peptide 
concentration versus time are shown, and a drop in peptide concentration over time is 
indicative of aggregation. 
1.5. Structural Propensity of Polyglutamine: Research Objective 
In light of the results of Thakur and Wetzel (2002),26 and the idea that a single 
polyQ chain serves as the critical nucleus for aggregation (see Section 1.2), it was likely 
---
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that the inhibitory effects of Thakur and Wetzel's proline mutations on aggregation of the 
variants of PGQ9 (Figure 9) are due to effects on the structural tendency of the monomer, 
which disrupt its ~-sheet structural propensity. However, Thakur and Wetzel did not 
make a detailed interpretation regarding the nature of such ~-sheet structure disruption. 
Therefore, in the current study I will be examining, via computer simulations, the 
monomer structural propensities of a subset of Thakur and Wetzel's mutant peptides, in 
order to investigate the effect of Thakur and Wetzel's proline mutations. 
I hypothesize that the additional proline mutations within contiguous Q9 stretches 
of the variants of the PGQ9 peptide exert localized conformational restraint on the peptide 
backbone, confining the backbone to an existing tendency for polyproline type II (PPII) 
and/or turn/bend structure, for which both glutamine and proline residues have 
demonstrated a propensity.61 ,62 Such a localized restraint would in tum tend to confine 
the peptides to a native global preference for coil structure over ~-sheet structure, 
discouraging the already-unfavourable transition towards the ~-sheet structure required 
for aggregate nucleation/growth, and so would provide a structural explanation for the 
inhibition of aggregation observed for these peptides. Indeed, a recent computational 
study by Vitalis et al. (2008)63 proposed that a key factor in polyQ chain association is 
spontaneous conformational fluctuations within the polyQ monomer, and additional 
computational studies 64 , 65 have also suggested that spontaneous conformational 
fluctuation is involved in the transition toward ~-sheet-like structure. 
To investigate the above hypothesis, I will be examining the structural 
propensities of selected mutant peptides using simulated annealing molecular dynamics 
(SA-MD). This procedure was chosen in order to bias the molecular structure sampling 
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towards low-energy structures, as such structures would be most likely to be explored 
during folding, and thus exert the strongest overall influence on monomer properties. In 
this technique, an MD simulation is first equilibrated at a high temperature, and then the 
temperature is slowly reduced to a low final temperature, allowing the simulated polyQ 
chain to gradually fold into its energetically-optimal structure(s).66 A number of SA-MD 
simulations will be performed on the PGQ9 mutant, which aggregated with similar 
efficiency to that of non-mutated polyQ, and was proven to have similar aggregate 
structure (see Section 1.4).26 In addition, the PGQ9(pl) and PGQ9(p2,3) mutants will be 
simulated, as sample cases of the PGQ9 variants with additional proline insertions (see 
Table 1). PGQ9(pl) was chosen as the one peptide with an additional proline in only a 
terminal polyQ segment of the PGQ9 sequence, and slowed, but not abolished, 
aggregation. Meanwhile, PGQ9(p2,3) was chosen as a peptide with additional prolines in 
only central polyQ segments of the PGQ9 sequence, and completely abolished 
aggregation. Finally, the three selected peptides were chosen with the consideration that 
they all possess the same number of amino acid residues, and the same tum-inducing 
proline-glycine pairs, thus ensuring consistency among the peptides apart from the 
additional prolines OfPGQ9(p l) and PGQ9(p2,3). 
In all simulations, the carboxy-terminal end of each polyQ peptide will be 
constrained to a ~-tum-~-strand structure, in accordance with the tum-strand structure 
deduced previously for PGQ9 (see Section 1.4).26,41 Such a constraint was chosen to 
simulate a situation in which ~-structure formation has initiated due to interaction with a 
seed or a growing oligomer/aggregate, thus permitting a sampling of structures that are 
possible in such a situation. At the same time, however, the chosen constraint was held 
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away from the sites of the additional glutamine~proline mutations of PGQ9(pl) and 
PGQ9(p2,3) (see Table 1) - where imposition of ~-strand constraints would be 
problematic - thus allowing these parts of the peptide to form whatever structure types 
would be energetically-accessible during the simulations. Although this may seem to be 
a crude representation of polyQ monomer-assembly association, such representation 
would permit an assessment of structural effects that occur within the monomer, rather 
than due to interactions between monomers. 
Structures generated by the SA-MD simulations will then be subjected to a 
number of structural analyses, including backbone dihedral calculations, local secondary 
structure assessment with the Dictionary of Protein Secondary Structure (DSSP),67 
automated histogram filtering (AHF) cluster analysis,68,69 and assessment of global ~­
sheet structure formation by counting of "in-register contacts.,,64 In addition, the 
structures will be subjected to energy calculations by molecular mechanics and quantum 
mechanics methods, in order to assess whether appreciable non-bonded perturbations of 
peptide structure are present in PGQ9(P I) and PGQ9(p2,3) - relative to PGQ9 - or if any 
perturbations are mainly local, geometry-based ones as hypothesized. Based on the 
results, the effect of Thakur and Wetzel's mutations on the structural propensities of the 
polyQ peptides will be assessed, and the hypothesis of conformational restraint will be 
addressed. If such alteration to structural propensity is observed, then the results will 
suggest that the mutations indeed discourage the formation of ~-sheet structure via 
effective entrapment in native coil structure, thus resulting in the inhibition of 
aggregation observed by Thakur and Wetzel. Such information would indicate 
conformational restraint to be a possible means of inhibiting polyQ aggregation, which 
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could one day lead to the development of effective rational inhibitors of polyQ 
aggregation that are based on such a mechanism, thus paving the way for effective future 
treatments of HD and other polyQ-associated diseases. 
2. METHODS 
2.1. Simulated Annealing Molecular Dynamics (SA-MD) 
2.1.1. Some Simulated Annealing Background 
Simulated annealing is a technique for molecular structure optimization that was 
originally developed by Kirkpatrick et al. (1983).70 Simulated annealing was originally 
used to find the global-optimum state for simple atomic/molecular systems, but has also 
been applied to peptides, and to other multidimensional optimization problems such as 
the travelling salesman calculation.66,70 
In the technique of SA-MD, an MD simulation is first equilibrated at a high 
temperature (500-1000 K), which allows the simulated peptide to efficiently explore 
conformational space by passing over barriers in the peptide folding potential energy 
landscape. Then, the temperature is slowly reduced to a low final temperature (usually 
50 K), during which the simulated peptide gradually folds into an energetically-optimum 
structure(s). Although in principle, simulated annealing can locate the global minimum 
with an ideal cooling schedule, in practice it is difficult, if not impossible, to find the 
global-optimum structure of a peptide due to the complexity of its potential energy 
function. Still, the technique has proven very useful for efficient sampling of low-energy 
structures. Therefore, the technique was chosen in order to fulfill the goal of sampling 
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low-energy structures for the peptides in question, and thus permit examination of the 
properties of such structures. 
2.1.2. Preparation of Initial Polyglutamine Peptide Structures 
Structures of Thakur and Wetzel's PGQ9, PGQ9(pl) and PGQ9(p2,3) mutant 
peptides (see Table 2), each in an extended conformation, were constructed using 
CHARMm 31.1 molecular modeling software, 7 1 and saved as protein databank (PDB) 
coordinate files. The terminal lysine residues of all peptides were replaced with neutral 
amino-terminal acetyl and carboxy-terminal N-methylamine capping groups, in order to 
exclude any structural effects that may otherwise arise from electrostatic interactions 
between charged ends. Accompanying protein structure parameter files for use in the 
simulations were also constructed using CHARMm 31.1, implementing parameters from 
the CHARMm22 force field. 72 
Table 2: Polyglutamine Peptides Under Examination 
Polyglutamine Peptide Amino Acid Sequencea 
PGQ9 Ace-Q9-PG-Q9-PG-Q9-PG-Q9-Nme 
PGQ9(p 1) Ace-Q4PQ4-PG-Q9-PG-Q9-PG-Q9-Nme 
PGQ9(pL ,J) Ace-Q9-PG-Q4PQ4-PG-Q4PQ4-PG-Q9-Nme 
aAce = amino-terminal acetyl cappmg group; Nme = carboxy-termmal N-methylamme 
capping group. The four polyglutamine segments of each peptide are highlighted in bold. 
Initial local energy minimizations of the extended structures were then performed 
using NAMD 2.6 molecular dynamics simulation software,73 in order to remove atomic 
clashes within the structures. Minimization was performed using the conjugate gradient 
algorithm, and was executed in vacuo for 2000 steps without constraints, using the same 
CHARMm22 energy parameters implemented in the subsequent SA-MD simulations. 
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All minimizations were executed on a 2.2 GHz quad-core Opteron computer system at 
SHARCNET/4 using four CPUs per run. Before continuing the structure preparation 
process, the presence of ~-strand structure after minimization was confirmed by 
examination with VMD 1.8.4 molecular viewing software. 75 
Next, in order to permit application of the desired constraints, a ~-turn was 
generated between the third and fourth polyQ segments of each peptide. To achieve this, 
the intervening proline-glycine pair was set to backbone dihedral angles necessary for a 
Type II ~-turn. Indeed, proline-glycine pairs are known to be readily-compatible with 
this type of turn, 76 and the PGQ9 ~-sheet structures reported in the literature demonstrated 
strand I-strand 2 and strand 3-strand 4 turns resembling Type II ~-turn geometry.41 ,54 
Using the Torsion Monitor tool of ArgusLab 4.0.1 molecular modeling software,77 the 
proline and glycine dihedral angles were set to (<p = -60°, \If = 120°) and (<p = 90°, \If = 0°), 
respectively, in accordance with dihedrals previously reported for Type II ~_turns.76 
Then, conjugate gradient energy minimization was repeated for 200 steps to remove any 
remaining atomic clashes (with a final energy gradient of <0.1 kcal/mol·A), and the 
resulting structure was examined with VMD 1.8.4 to confirm the presence of a ~-turn. 
2.1.3. SA-MD Simulations 
As with the energy minimizations, all SA-MD simulations were performed using 
NAMD 2.6 molecular dynamics simulation software,73 and executed on a 2.2 GHz quad-
core Opteron computer system at SHARCNET. 74 Eight CPU s were used for each 
simulation, as this number of processors had been determined to yield the fastest run 
completion times, according to a series of test runs (data not shown). In order to account 
for the previously-reported native preference of polyQ for non-~-sheet structure (see 
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Section 1.2), a non-~-structure-biased force field - the CHARMm22 force field72 - was 
implemented throughout the simulations. In addition, solvent effects were represented by 
attenuating the electrostatic component of the force field using a fixed dielectric constant. 
This method of solvent effect representation was chosen to ensure good computational 
efficiency, and the dielectric constant was set to a value of 10.0, in accordance with the 
solvent-excluded regions of a polar uncharged peptide's structure. 78 
A timestep of 1.0 fs was implemented throughout, with non-bonded interactions 
evaluated every 2.0 fs using a RESPA multiple time step integrator algorithm. 79 All 
covalent bonds to hydrogen atoms were constrained using the SHAKE algorithm.8o The 
non-bonded cutoff distance was set to a value of 500.0 A - a greatly exaggerated value 
compared to the fully-extended length of the peptides - in order to perform simulations 
that effectively have no cutoff for the non-bonded interactions, thus eliminating cutoff-
related bias. 
In all simulations, the carboxy-terminal end of each polyQ peptide was 
constrained to a ~-turn-~-strand structure comprising amino acid residues 31-42 - i. e. the 
carboxy-terminal fourth polyQ segment and preceding four-residue turn (see Section 1.5; 
Figure 10). Indeed, test simulations of PGQ9 in which the fourth polyQ segment was 
constrained to ~-strand structure without a constrained ~-turn (data not shown) indicated 
the partial formation of ~-hairpin structure between the third and fourth polyQ segments, 
thus validating the inclusion of a turn as part of the constraints. Harmonic atom position 
constraints were applied to the a-carbon atoms of the constrained residues, the carbon 
and nitrogen atoms of the intervening peptide bonds, and the peptide bond nitrogen atom 
of residue 31, based on the positions of the atoms after completion of the initial structure 
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preparation (Section 2.1.2). Harmonic constraints were chosen in order to maintain the 
desired structure while still permitting some structural flexibility during the simulations. 
All constraints were applied using NAMD's intrinsic constraint function, with a 
relatively large force constant of 7.50 kcal/mol·A2 to ensure proper maintenance of the 
constraints at the high temperatures of the SA-MD simulations. 
Figure 10: Stick model illustration of the ~-turn-~-strand constraints applied to the 
carboxy-terminal end of the simulated peptides. The PGQ9 peptide is illustrated as an 
example (image generated using Swiss-PdbViewer 3.781 ), and for clarity, amino acid side 
chains have been omitted. The polyglutamine segments are highlighted in orange, and 
the proline-glycine amino acid residue pairs are highlighted in blue and white 
(blue=proline, white=glycine). Residues at the ends of the third and fourth 
polyglutamine segments are labeled according to their numbers in the amino acid 
sequence, and the constrained amino acid residues are highlighted by a yellow ribbon. 
For each peptide, a series of 25 independent, high-temperature MD simulations 
were performed, starting from the prepared ~-hairpin-containing initial structure. In these 
simulations, the peptides were heated linearly from 0 K to 900 Kover 20 ps, and then 
simulated at 900 K (NVE ensemble) for another 11 ns. Throughout the simulations, the 
temperature was maintained at 900 K using the velocity rescaling protocol. The structure 
of the peptide was saved every 500 ps, thus ensuring that the saved structures would not 
be appreciably correlated with one another. However, all structures prior to 1.5 ns were 
ignored in order to permit 1.5 ns of initial equilibration, in accordance with the required 
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1.5 ns equilibration period observed previously for similar-sized peptides.82 In total, a set 
of 500 high-temperature structures (20 structures from each high-temperature simulation) 
were generated for subsequent use in SA cooling simulations. 
Next, each of the 500 high-temperature structures was subjected to a SA cooling 
simulation. After initialization of the intramolecular forces and energies, the structure 
was cooled exponentially from 900 K to a final temperature of 50 Kover 10 ns. This was 
accomplished using an iterative cooling protocol, in which the temperature was reduced 
every 100 fs to a large fraction ("f') of the preceding temperature, in accordance with the 
exponential cooling protocol of Barakat and Dean (1990):83 
T(t) = To·e-At = ToJ (1) 
where T(t) is the temperature at time t; To is the initial temperature; and A and fare 
positive constants whose values are pre-calculated to fit the exponential temperature 
trend to the desired schedule (in this case, A = 2.89 x 10-4 pS-l and f = 0.9997). Finally, 
the peptide was equilibrated at 50 K for 100 ps, and the final structure was saved for 
subsequent analysis. Throughout the simulations, the temperature was maintained along 
the desired trend of cooling and final equilibration using the velocity rescaling protocol. 
In total, 500 final structures were generated for each of the three peptides. This 
number of structures was comparable to the numbers of structures generated previously 
by SA-MD for other peptides,84 and was therefore likely to represent a sufficiently large 
sample of structures for analysis. 
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2.2. Peptide Comparisons: Local Structure Analysis 
The local secondary structure tendencies exhibited by the structures generated for 
each of the three peptides were characterized by a combination of two methods: 
calculation of peptide backbone dihedrals (q> and 'If), and analysis using the Dictionary of 
Protein Secondary Structure (DSSP).67 The backbone dihedrals for each peptide were 
computed using the Torsion Trace tool of the Quanta 2005 molecular modeling software 
package. 85 In order to permit efficient analysis, the structures for each peptide were 
collected into a single trajectory file (DCD-format) prior to input into Quanta. The 
calculated dihedrals were then plotted as two-dimensional (q>, 'If) dihedral frequency 
histograms (see Figures 24-27) using Origin 7.5 graphing software.86 The analysis was 
performed on the first three polyQ segments, while ignoring the fourth segment to avoid 
structural bias resulting from the constraints (see Figure 10) applied to this segment 
during the SA-MD simulations. In particular, the central seven residues of each polyQ 
segment were examined, since it is these residues that would give rise to the ~-strands of 
the antiparallel ~-sheet aggregate structure deduced previously for PGQ9 (see Section 
1.4).26,41 
The DSSP analysis of the peptides was performed using the Dictionary of Protein 
Secondary Structure software package. 67 This software identifies secondary structure 
types adopted by each amino acid residue, based on a combination of backbone hydrogen 
bond and geometry criteria (see Appendix C for details). In total, seven structure types 
were examined: 31O-helix; a-helix; n-helix; hydrogen-bonded ~-structure; hydrogen-
bonded turns; non-hydrogen-bonded bends; and non-hydrogen-bonded loop/irregular 
structure (which includes PPII structure). Creation of the necessary PDB-formatted input 
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structure files for each peptide, and compilation of the analysis results, was carried out 
using computer programs written in Fortran77. The number of residues per peptide 
structure that exhibited each secondary structure type was then plotted for each of the 
three peptides as frequency histograms, using Origin 7.5 (see Figure 28). The analysis 
was performed on the central seven residues of each of the first three polyQ segments, 
while ignoring the fourth segment, for reasons similar to those of the dihedral analysis 
(see above). 
2.3. Peptide Comparisons: Potential Energy Analysis 
In addition to structural analyses of the three peptides, potential energies of the 
peptide structures were also examined, using a combination of CHARMm molecular 
mechanics energy calculations, and quantum mechanics energy calculations based on 
fragment molecular orbital (FMO) methodology.87 This was done to determine whether 
the additional glutamine--joproline mutations introduced in PGQ9(pl) and PGQ9(p2,3) 
exerted appreciable non-bonded perturbations of peptide structure - i. e. beyond the 
inherent loss of hydrogen-bonding functional groups incurred by the glutamine--joproline 
mutations - or if the effects of these mutations are primarily local, geometry-based ones, 
in accordance with the local structure analysis results. 
Prior to performing any potential energy calculations, the structures of each 
peptide were energy-minimized for 100 steps using NAMD 2.6 (with a final energy 
gradient of<O.1 kcalimol·A).73 This step was necessary because due to the nature of the 
molecular mechanics potential energy functions (see Appendix B), even small structural 
perturbations can make a big difference to the calculated potential energies. Thus, the 
final minimization was necessary in order to remove energetic artifacts from the 
29 
structures, even though the minimization would have made negligible structural 
difference to peptide structures generated at a final simulation temperature as low as 50 K 
(as was done in the current study). Minimization was performed using the conjugate 
gradient algorithm, and implemented the same energy calculation parameters used in the 
SA-MD simulations - including the same harmonic constraints (see Section 2.1.3). All 
minimizations were executed on a 2.2 GHz quad-core Opteron computer system at 
SHARCNET/4 using 8 CPUs per run. 
2.3.1. Analysis of Molecular Mechanics Backbone Potential Energies 
In order to permit examination and comparison of the peptide backbone potential 
energies, without the energy contributions of the side chains, polyglycine versions of the 
energy-minimized peptide structures were constructed. To accomplish this objective, 
modifications to the atoms of all glutamine and proline residues were made within the 
respective DCD trajectory files, and input PDB files, using programs written in Fortran77. 
These modifications included replacement of all glutamine and proline residue side 
chains with hydrogen atoms - the side chain of glycine - as well as addition of a 
hydrogen atom to the peptide bond nitrogen of each proline residue - which has one 
fewer hydrogen atom than the peptide bond nitrogens of other amino acid residues -
while retaining the terminal capping groups (see Figure 11). Accompanying protein 
structure parameter files were then constructed using CHARMm 31.1,71 once again 
implementing parameters from the CHARMm22 force field. 72 Finally, the positions of 
the new hydrogen atoms in the structure were optimized by 100 steps of conjugate 
gradient energy minimization using NAMD, with fixed-atom constraints applied to the 
rest of the peptide to prevent structure alteration during the energy minimization. 
(a) 
Glutamine Proline 
(b) 
Ace-Q9-PG-Q9-PG-Q9-PG-Q9-Nme 
Ace-Q4PQ4-PG-Q9-PG-Q9-PG-Q9-N me 
Ace-Q9-PG-Q4PQ4 -PG-Q4PQ4 -PG-Q9-Nme 
30 
Glycine 
Figure 11: (a) Structural modifications made to the glutamine and proline residues of 
PGQ9, PGQ9(pl) and PGQ9(p2,3) during construction of the corresponding polyglycine 
structures. Green box = side chains; red box = peptide bond hydrogen atoms. (b) Amino 
acid sequence transformations achieved by the modifications. Ace = amino-terminal 
acetyl capping group; Nme = carboxy-terminal N-methylamine capping group. 
The CHARMm22 molecular mechanics potential energIes of the polyglycine 
structures for all three peptides were then computed using NAMD. All calculations were 
performed using the same energy calculation parameters implemented in the SA-MD 
simulations (see Section 2.1.3), and using programs written in Fortran77, the total bonded 
(geometric) and non-bonded potential energies were computed from the NAMD output as 
follows: 
Ebonded = Ebond + Eangle + Edihedral + Eimproper (2) 
Enon-bonded = E VDW + Eelectrostatic (3) 
where Ebond, Eangle, EdihedraJ, Eimproper, EyDW and Eelectrostatic are the total computed 
CHARMm22 bond-stretching, bond-angle-bending, dihedral (bond rotation), improper 
dihedral, van der Waals and electrostatic energies, respectively (see Appendix B for 
details). The resulting bonded and non-bonded backbone potential energies were then 
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plotted as frequency histograms using Origin 7.5 graphing software,86 with the results for 
all three peptides plotted on a single set of graphs for comparison (Figure 29). 
2.3.2. Analysis of Molecular Mechanics Total Potential Energies 
In addition to backbone potential energies, CHARMm22 molecular mechanics 
potential energies including the amino acid side chains were also computed. However, 
the inherent differences between the peptides, and thus between their molecular 
mechanics potential energy functions, necessitated the exclusion of functional groups that 
were not common to all three peptides in order to achieve a meaningful comparison of 
the peptides' energies. In order to accomplish this, the energy calculations were 
performed only on functional groups that were common to all three peptides, which were 
specified during the calculation using NAMD's intrinsic Pair Interaction tool. 
Two sets of CHARMm22 molecular mechanics potential energies including side 
chains were calculated for all three peptides. The first set of energies was calculated 
across the entire peptide structure, except for the central residues of the first, second and 
third polyQ segments - residues 5, 16 and 27 - where the glutamine----+proline mutations 
introduced in PGQ9(pl) and PGQ9(p2,3) occur (see Table 2, Section 2.1.2). The second 
set of energies was calculated across the entire peptide structure, except for the o-carbon 
functional groups and peptide bond hydrogen atoms of residues 5, 16 and 27, which are 
the specific sites of the functional group substitutions associated with the 
glutamine----+proline mutations (Figure 12). All calculations were performed using the 
same energy calculation parameters implemented in the SA-MD simulations, and using 
programs written in Fortran77, the total bonded (geometric) and non-bonded potential 
energies were computed from the NAMD output (Equations 2 and 3). The resulting 
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bonded and non-bonded potential energies were then plotted as frequency histograms 
using Origin 7.S graphing software, with the results for all three peptides plotted on a 
single set of graphs for comparison (Figures 30 and 31). 
Proline 
Figure 12: Functional group substitutions associated with the glutamine-proline 
mutations introduced in PGQ9(pl) and PGQ9(p2,3). Green box = b-carbon functional 
groups; red box = peptide bond hydrogen atoms. 
2.3.3. Analysis of Quantum Mechanical FMO Potential Energies 
In order to confirm whether the occurrence of potential energy differences 
between the peptides, as determined by molecular mechanics, is consistent with what 
quantum mechanics would indicate, quantum-mechanical potential energy calculations 
were performed on the three peptides. Such examination of energies by an alternative 
type of methodology was deemed necessary due to the possibility of non-corresponding 
energy terms for the structures of the three peptides - a possibility that is inherently 
associated with CHARMm22 molecular mechanics potential energy comparisons 
between different peptides. The quantum-mechanical potential energy calculations were 
performed using a fragment molecular orbital (FMO) methodology developed specially 
for examination of proteins and peptides.87 In this method, a peptide/protein is divided 
into amino acid monomers ("fragments"; see Figure 13), and quantum-mechanical energy 
calculations are performed to obtain the energies of all amino acid monomers, and the 
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energies of interaction between all pairs of monomers. Once these energies are obtained, 
the total local conformational (FMO geometric) and long-range non-bonded potential 
energies can then be computed for the peptide/protein structure in question (as described 
below in Equations 5 and 6). 
R1 0 R3 0 R5 
~I ~~~ ,Jl ~1 ~~_ ,Jl ~I ,OH 
H2N" · IIr I ' ~~~ IIr I ' ~~~ In 
o R2 o R4 o 
Figure 13: Peptide fragmentation scheme employed by FMo.87 All fragmentations 
between amino acid monomers occur across backbone Cu-C bonds (as indicated by green 
dotted lines). 
Before performing the quantum-mechanical energy calculations, representative 
structures needed to be selected for analysis from among the structures of each peptide. 
The complete sets of structures could not be analyzed, due to computational expense 
issues with the computer system on which the analysis software was run. To select 
representative structures, automated histogram filtering (AHF) cluster analysis68,69 was 
performed on the structures of each peptide. 
AHF is a cluster analysis method capable of sorting molecular structures into 
distinct groups, based on geometric similarity. The method rests on performing a 
principal component analysis on each set of structures, with the inter-a-carbon distances 
as variables. Then, frequency histograms of the variable factor scores - i.e. values of 
projections of the variables onto each principal component - are computed and scanned 
for peaks, each of which corresponds to a cluster of geometrically-related structures (see 
Figure 14 for example histogram). When a division into clusters occurs, the whole 
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procedure is then repeated on each of the clusters that are obtained, until they cannot be 
further sub-divided into smaller clusters. Throughout the process, the number of peaks 
that are identified is regulated by a parameter called the "peak distinction," in order to 
filter out random noise in the data, which would otherwise result in identification of an 
excessive number of clusters (see Figure 14). 
apparent 
peakl 
\ well 
apparent 
~---.. peak 2 
Principal component factor score 
Figure 14: Scheme for identification of peaks in the AHF factor score histograms.68,69 A 
simplified histogram is shown, with the factor scores for the corresponding principal 
component plotted along the horizontal axis, and the number of molecular structures 
exhibiting each factor score plotted along the vertical axis. The well depth is defined as 
the distance from the bottom of the well between two apparent peaks, to the top of the 
shorter peak. If this distance is greater or equal in magnitude to the peak distinction 
parameter, then the two apparent peaks are accepted as actual peaks (each corresponding 
to a distinct cluster), rather than random noise in the histogram. Therefore, as the peak 
distinction value is reduced, the chance of apparent clusters being accepted as distinct 
clusters increases. 
The AHF method has an advantage in that unlike conventional RMSD-based 
clustering, AHF examines collective patterns of structural variation in a molecular 
structure sample as a whole, rather than differences for discrete pairs of structures within 
the sample. As a result, AHF can more effectively assess true patterns of variation 
among the sample structures than RMSD-based clustering, and can account for variation 
patterns that RMSD-based clustering may not detect. In addition, by focusing the 
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analysis only on key atoms of the peptide backbone (i.e. a-carbon atoms), AHF is less 
likely to be affected by variational noise in the data than are RMSD-based methods 
which examine all atoms or all backbone atoms. 
The AHF analysis was carried out usmg a Fortran-based software package 
developed by members of the Rothstein research group,68,69 in which principal 
component calculations were performed with SHARCNET's AMD ScaLAP ACK 
library.74,88 The peak distinction parameter was set to a value of 5, which was found to 
yield maximum numbers of representative structures (see below for selection criteria) for 
the three peptides, without introducing noise into the results (as evidenced by very large 
numbers of clusters; data not shown). The data input parameters for AHF clustering were 
adjusted to the necessary values for the structures of each peptide (i.e. 500 structures, 
each with 42 a-carbons and 42*41 /2 inter-a-carbon distances), and the CPU memory 
allotment parameters were adjusted accordingly. The analysis was run on 4 CPUs of a 
2.2 GHz quad-core Opteron computer system at SHARCNET. Once clusters were 
obtained, the most representative structure from each cluster was then identified, based 
on the criterion that the structure must exhibit minimum total mean-square deviation 
(MSD) in inter-a-carbon distances from all other structures in the cluster:68,69 
all sirues 
MSD'o'al (i) = L 
all dists L (dist"k - dist i ,k) 2 
k 
N diSIS 
= minimum 
(4) 
where dist is the kth inter-a-carbon distance of the ith/jth peptide structure, and Ndists is the 
number of inter-a-carbon distances per structure. In total, eight representative structures 
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for PGQ9, 12 for PGQ9(p l ), and 14 for PGQ9(p2,3) were selected for subsequent FMO 
analysis (see Appendix A), 
Analysis of the representative structures by FMO was carried out usmg the 
ABINIT-MP software package.87,89 Using programs written in Fortran77, each of the 
structures was compiled into a PDB-formatted structure file for input into ABINIT-MP. 
During the calculations, the MP2 methodology was employed in order to properly 
account for both electrostatic and electron correlation effects.9o In addition, the 6-31 G 
basis set was used for the molecular orbitals, since this basis set has proven very effective 
in previous studies of proteins.91 All calculations were executed on 16 CPUs of a 2.0 
GHz, dual-core Opteron computer system at Kobe University, and using programs 
written in Fortran77, the total local conformational (FMO geometric; Elocal conf) and long-
range non-bonded (Elong-range NB) potential energies for each structure were computed from 
the ABINIT-MP output as follows: 
E local can! = IE; + I E; ,;+1 (5) 
E long- range Nfl = I I E; ,j (6) 
; j ??:;+2 
where Ei is the energy of amino acid monomer i; E i,i+1 is the energy of interaction 
between monomers i and i+ 1, which are adjacent to each other in the amino acid 
sequence; EiJ is the energy of interaction between monomers i and j , which are not 
adjacent to each other. In order to achieve a meaningful comparison of the peptides' 
energies, the monomers corresponding to the central amino acid residues of the first, 
second and third polyQ segments - where the glutamine----tproline mutations introduced 
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in PGQ9(pl) and PGQ9(p2,3) occur (see Table 2) - were excluded from the total energy 
calculations. 
2.3.4. Comparison o/Quantum Mechanical FMO Potential Energies 
With Molecular Mechanics Potential Energies 
In order to permit an effective comparison between the quantum mechanics and 
molecular mechanics potential energy results, another set of molecular mechanics 
potential energies was computed, following energy definitions analogous to those of the 
FMO method.87 The results of the quantum mechanics and molecular mechanics 
calculations were then compared for signs of consistency in the presence/absence of 
appreciable potential energy differences among the peptides. 
For each peptide structure, CHARMm22 molecular mechanics potential energies 
were computed using NAMD for the entire peptide, for each amino acid monomer, and 
for each pair of adjacent monomers. Amino acid monomers were delineated based on the 
same scheme used in the FMO procedure (Figure 13), and during each energy calculation, 
the portiones) of the peptide to be analyzed were specified using NAMD's intrinsic Pair 
Interaction tool. All calculations were performed using the same energy calculation 
parameters implemented in the SA-MD simulations (see Section 2.1.3). Using programs 
written in Fortran77, the total CHARMm22 molecular mechanics local conformational 
(Elocal con f) and long-range non-bonded (Elong-range NB) potential energies of all peptide 
structures were then computed from the NAMD output as follows: 
Emonomer(i) = Ebonded(i) + Enon-bonded(i) (7) 
Emonomer pair(i and i+ /) = Ebonded monomer pair(i and i+ /) + Enon-bonded monomer pair(i and i+ 1) (8) 
Edimer(i,i+ /) = Emonomer pair(i and i+ /) - Emonomer(i) - Emonomer(i+ /) (9) 
E tata! peptide = Ebanded peptide + Enan-banded peptide 
Elacal conI = I E manamer(i ) + I E dimer(i,i+ I) 
E/ang-range NB = E tata! peptide - E!aca/ canf 
(10) 
(11) 
(12) 
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where Emonomer(i) is the total energy of monomer i; Emonomer pair(i and i+]) is the total energy of 
the dimer composed of monomers i and i+ 1, which are adjacent to each other in the 
amino acid sequence; Edimer(i,i+]) is the energy of interaction between monomers i and i+ 1; 
Etota] peptide is the total energy of the peptide; and the Ebonded and Enon-bonded terms are the 
respective total bonded and non-bonded energies, computed according to Equations 2 and 
3. 
As with the calculations of the FMO total energies (see Section 2.3.3 above), the 
ammo acid monomers corresponding to the central amino acid residues of the first, 
second and third polyQ segments were excluded from the calculations. The resulting 
CHARMm22 molecular mechanics local conformational and long-range non-bonded 
potential energies were then plotted as frequency histograms using Origin 7.5 graphing 
software,86 with the results for all three peptides plotted on a single set of graphs for 
comparison (Figure 34). 
2.3.5. Molecular Mechanics Total Potential Energies: Further Analysis 
As a final assessment of peptide potential energies, to further examme the 
localization of the differences in bonded/local conformational energies that were 
observed among the three peptides (Sections 3.3.1 and 3.3.2), the CHARMm22 
molecular mechanics and FMO analyses of total potential energy (Sections 2.3.2, 2.3.3 
and 2.3.4) were repeated. This time, however, the calculations excluded the central 
amino acid residues of the first, second and third polyQ segments, and the residues 
39 
immediately amino-terminal to the central residues - which were also affected by the 
glutamine~proline mutations introduced in PGQ9(pl) and PGQ9(p2,3), as observed from 
the peptide backbone dihedrals analysis (see Section 3.2.1). 
2.3.6. Statistical Evaluation of Differences in Potential Energy 
Due to the small numbers of peptide structures analyzed in each set of quantum-
mechanical energy calculations, similarities/differences would have been very difficult to 
detect graphically as with the full complement of conformations obtained by SA-MD. 
Therefore, in order to check for significant differences among the three peptides, the 
respective sets of local conformational and long-range non-bonded energIes were 
compared using a 10nckheere k-sample test (results shown in Table 4).92 In addition, all 
sets of CHARMm22 molecular mechanics energies in which a difference was observed 
graphically were subjected to the k-sample test, to confirm whether or not the difference 
was significant (results shown in Table 3). 
As prescribed by 10nckheere,92 the normal approximation was applied to the large 
samples, and the Student's t approximation was applied to the smaller samples (for test 
details, see Appendix D). In order to ensure maximum confidence in the test results, all 
tests were performed at the 1 % significance (99% confidence) level. The tests were 
performed in two-tailed format, and all calculations were executed usmg programs 
written in Fortran77. 
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2.4. Peptide Comparisons: Global Structure Analysis 
To conclude the comparative analysis of the three peptides, the effects of the 
glutamine---+proline mutations introduced in PGQ9(pl) and PGQ9(p2,3) on global 
structural tendency were assessed. This was accomplished using a combination of 
automated histogram filtering (AHF) cluster analysis68,69 to assess patterns of global 
structure variation, as well as counting of "in-register contacts,,64 to assess the extent of 
global ~-sheet structure tendency. 
2.4.1. Automated Histogram Filtering (AHF) Cluster Analysis 
To assess global structure variation for each of the three peptides, automated 
histogram filtering (AHF) cluster analysis68,69 was performed on the structures of each 
peptide. This analysis was carried out with the same Fortran-based software that was 
used to select peptide structures for FMO analysis (see Section 2.3.3). Multiple AHF 
calculations were performed on the structures of each peptide, during which the value of 
the peak distinction parameter was varied incrementally, and the number of clusters 
identified at each peak distinction value was determined. All other parameters were set 
to the necessary values (as outlined in Section 2.3.3), and held constant throughout the 
analysis. The results for each peptide were then plotted as a graph of the number of 
identified clusters versus the peak distinction value (Figures 37 and 38), and compared 
for differences in the rate of increase in the number of clusters with decreasing peak 
distinction. Such an increase in the number of clusters can be expected because as the 
peak distinction value is reduced, the chance of possible clusters being accepted as 
distinct clusters increases (see Figure 14). 
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In this analysis, a greater rate of increase in the number of clusters for a given 
peptide, compared to the others, would be consistent with an internal fragmentation of the 
affected peptide's structural ensemble into smaller clusters. In this situation, while the 
structural ensembles of the non-affected peptides would have stronger tendency toward 
accounting for a continuous region of global structure space, the structural ensemble of 
the affected peptide would tend toward accounting for a more fragmented region of 
global structure space, with the overall diversity of structures remaining unaltered (see 
Figure 15). This would be consistent with the affected peptide lacking energetically-
favourable access to portions of global structure space that are readily accessible to the 
non-affected peptides. Therefore, the affected peptide would likely have access to a 
reduced proportion of global structure space - compared to the non-affected peptides -
which would in tum be consistent with increased global structural rigidity. 
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Figure 15: A possible situation consistent with a greater rate of increase in the number of 
identified clusters with decreasing peak distinction value, but unchanged overall 
structural diversity. A lower rate of increase corresponds with stronger tendency toward 
scenario (A), where low-energy structures constitute a continuous range of global 
structure space. A greater rate of increase, on the other hand, corresponds with stronger 
tendency toward scenario (B), where low-energy structures constitute a fragmented (i.e. 
discontinuous) range of global structure space. For each scenario, a rough representation 
of a corresponding peptide potential energy landscape is illustrated (bottom; side view 
shown), along with the top view of a horizontal cross-section (top) taken through a low-
energy region of each landscape (as indicated by a green dotted line). In addition, 
potential energy landscape variable axes for the side and top views are shown: SVl, SV2 
= variables describing peptide structure; PE = peptide potential energy. Although in 
reality peptide structure would be described by more than two variables, for simplicity 
only two structure variables are shown. 
However, the situation outlined above relies on the assumption that the structural 
ensembles for all three peptides are of comparable overall structure diversity, according 
to the inter-a-carbon distance variables implemented in the AHF analysis. Thus, in order 
to confirm whether the peptide structural ensembles were of comparable diversity, root-
mean-square deviations (RMSDs) were computed among all pairs of structures for each 
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peptide using Fortran77. As with the AHF calculations, all RMSDs were calculated 
based on inter-a-carbon distances within the structures: 
RMSDi,j = 
all disis I (dist/ ,k - dist i ,k)2 
k 
NdiSiS 
(13) 
where dist is the kth inter-a-carbon distance of the ith/jth peptide structure, and N dists is the 
number of inter-a-carbon distances per structure. The calculated RMSDs were then 
plotted as frequency histograms using Origin 7.5 graphing software (Figure 39),86 to 
permit examination of the distributions of RMSD values covered by each peptide. In the 
event that the RMSD distributions overlap, the peptide structure ensembles in question 
could be deemed as possessing comparable overall diversity, which would be consistent 
with the situation outlined above (Figure 15). 
Two sets of AHF and RMSD analyses were performed on each of the three 
peptides. In one set of analyses, the entire peptide was included in the calculations, to 
permit examination of flexibility across the entire structure of the peptide. In the second 
set of analyses, however, the carboxy-terminal end of the peptide - which was 
structurally-constrained during the SA-MD simulations (see Figure 10) - was excluded 
from the calculations, to permit examination of flexibility across only the portion of the 
peptide whose structure was free to vary during the simulations. 
2.4.2. In-Register Contacts: Assessment of Global fJ-Sheet Tendency 
Finally, the extent of global ~-sheet structure tendency was assessed for all three 
peptides. After attempting a number of methods for assessing global ~-sheet structure, 
including counting of ~-structure hydrogen bonds and imposition of a cutoff on DSSP ~-
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structure residue counts, counting of "in-register" contacts64 was selected as the 
quantitative method that could distinguish most effectively between the peptides. 
Numbers of "in-register" contacts were calculated for the structures of each peptide, in 
accordance with the antiparallel ~-sheet aggregate structure deduced previously for PGQ9 
(see Section 1.4).26,41 During this analysis, a contact between two amino acid residues 
was identified if the a-carbon atoms of the two residues were within a distance of 5 A 
from each other. A cutoff of 5 A was chosen because this distance is in line with the 
inter-~-strand distance of 4.8 A reported experimentally for polyQ peptides (see Section 
1.2), while still allowing a small amount of deviation from perfect ~-sheet structure. If 
identified, a contact between two amino acid residues was accepted as an "in-register" 
contact if it was one of the potential inter-residue contacts expected within the ideal 
antiparallel ~-sheet structure (see Figure 16). 
P21 G22 
Ql Q20 Q23 Q42 
Q2 ..... QI9 ..... Q24 . .... Q41 
Q3 ..... Q18 ..... Q25 . .... Q40 
Q4 ..... QI7 ..... Q26 . .... Q39 
Q5 ..... Q16 ..... Q27 . .... Q38 
Q6 ..... Q15 ..... Q28 . .... Q37 
Q7 ..... Q14 ..... Q29 . .... Q36 
Q8 ..... QI3 ..... Q30 . .... Q35 
Q9 Q12 Q31 Q34 
P IO Gil P32 G33 
Figure 16: Potential in-register contacts within the ideal antiparallel ~-sheet structure of 
PGQ9.26,41 The proline-glycine residue pairs are highlighted in red, the polyQ segments 
are highlighted in black, and the in-register residue-residue contacts are indicated by blue 
dotted lines between the two residues involved in each contact. 
,... 
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All calculations were carried out using programs written in Fortran77. The total 
numbers of in-register contacts per peptide structure were then plotted for each of the 
three peptides as frequency histograms (Figure 40), using Origin 7.5.86 
2.5. Control Studies of Non-Constrained Peptide Structures and 
Antiparallel p-Sheet Structures: Evaluation of Constrained SA-MD 
Protocol Success 
In order to assess the effectiveness of the SA-MD protocol with applied structural 
constraints, two sets of control analyses were performed on PGQ9. The PGQ9 peptide 
was chosen for these analyses because out of the three peptides examined in the current 
study, the experimental aggregation behaviour of PGQ9 most closely resembled that of 
non-mutated polyQ,26 and so this peptide would presumably form ~-sheet structure the 
most readily. 
2.5.1. Examination of Non-Constrained Peptide Structures 
The first of the two sets of control analyses was performed on a series of 500 
structures for PGQ9, for which no structural constraints were applied to the peptide. 
Structures of PGQ9 were generated using the same SA-MD protocol as was used 
previously (Section 2.1), except that no harmonic constraints were applied during the 
simulations. The resulting structures were then subjected to a DSSP-based local 
secondary structure analysis (as outlined in Section 2.2), and an analysis of in-register 
contacts (following the protocol outlined in Section 2.4.2), to assess the extent of ~-sheet 
structure tendency and how it compared to that of the constrained SA-MD structures. 
In addition, potential energies of the non-constrained SA-MD structures of PGQ9 
were computed using CHARMm22 molecular mechanics energy calculations, and 
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subsequently compared to the energies of the constrained SA-MD structures. As with 
analysis of the constrained SA-MD structures (see Section 2.3), the non-constrained 
structures were first energy-minimized for 100 steps using NAMD 2.6 (with a final 
energy gradient of <0.1 kcal/mol·A).73 Minimization was performed using the conjugate 
gradient algorithm, and implemented the same energy calculation parameters used in the 
other SA-MD simulations - except for the harmonic constraints, which were excluded 
this time. All minimizations were executed on a 2.2 GHz quad-core Opteron computer 
system at SHARCNET/4 using 8 CPUs per run. 
After minimization, CHARMm22 molecular mechanics potential energies were 
first computed across the entire peptide structure, using NAMD. Calculations were 
performed using the same energy calculation parameters implemented during 
minimization, and using Fortran77, the total bonded (geometric) and non-bonded 
energies were computed from the NAMD output according to Equations 2 and 3 (see 
Section 2.3.1). 
In addition, two additional sets of CHARMm22 molecular mechanics potential 
energies were computed. The first of these sets of energies was calculated across the 
entire peptide structure, except for the residues responsible for forming the three four-
residue turns of the PGQ9 antiparallel ~-sheet structure (i.e. residues 9-12, 20-23 and 31-
34; see Section 1.4).26 The final set of energies was calculated across the peptide 
structure, excluding the residues responsible for forming the three four-residue turns of 
the ~-sheet structure, as well as the side-chain atoms of the remaining amino acid 
residues - i.e. focusing only on the backbone atoms of the ~-strand-forming segments of 
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PGQ9. In both cases, the peptide functional groups to be analyzed were specified during 
the calculations using NAMD's intrinsic Pair Interaction tool. 
2.5.2. Antiparallel fJ-Sheet Structures: Structure Generation 
The second of the two sets of control analyses was performed on a number of 
four-stranded antiparallel ~-sheet structures generated for PGQ9. To generate these 
structures, an energy-minimized extended structure of PGQ9 was first prepared, 
following the same protocol outlined in Section 2.1.2. Then, three ~-hairpin turns were 
generated within the structure, producing an initial structure for subsequent energy 
minimization. In order to generate the turns between the first and second polyQ 
segments of PGQ9, and between the third and fourth polyQ segments, the respective 
proline-glycine residue pairs were each set to backbone dihedral angles necessary for a 
Type II ~-turn. Indeed, the PGQ9 ~-sheet structures reported in the literature 
demonstrated strand I-strand 2 and strand 3-strand 4 turns resembling Type II ~-turn 
geometry.41 ,54 Using the Torsion Monitor tool of ArgusLab 4.0.1 molecular modeling 
sofiware,77 the proline and glycine dihedral angles were set to (<p = -60°, 'If = 120°) and (<p 
= 90°, 'If = 0°), respectively, in accordance with dihedrals previously reported for Type II 
~_turns.76 
Generation of the tum between the second and third polyQ segments, however, 
could not be performed as described above, as the PGQ9 ~-sheet structures reported in the 
literature clearly demonstrated a strand 2-strand 3 tum with non-standard geometry.41 ,54 
In order to establish a best estimate of the backbone dihedrals necessary for this tum, the 
dihedrals of the proline-glycine pair, as well as those of the flanking glutamine residues 
(which should also participate in turn formation, according to Thakur and Wetzel, 
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200226), were adjusted by eye using the Torsion tool of Swiss-PdbViewer 3.781 until a 
suitable ~-hairpin alignment of the second and third polyQ segments was achieved, with 
a turn geometry visibly comparable to that reported in the literature.41 ,54 From this 
assessment, it was determined that the following best-estimate dihedrals would be 
necessary to pre-set the turn: (<p = -46°, \jf = -67°) for glutamine 20; (<p = -80°, \jf = 161°) 
for proline 21; (<p = 36°, \jf = 113°) for glycine 22; and (<p = -79°, \jf = 155°) for glutamine 
23. These dihedrals were then set using the Torsion Monitor tool of ArgusLab 4.0.1 77 (as 
the Swiss-PdbViewer software was unable to process the structural data for the peptide's 
terminal capping groups). 
Once the three ~-hairpin turns had been set, the resulting preliminary ~-sheet was 
then subjected to an initial energy minimization process using CHARMm 31.1 to remove 
atomic clashes, and complete the generation of the initial ~-sheet structure. As with the 
SA-MD simulations (Section 2.1), the CHARMm22 force field72 was implemented, and 
solvent effects were represented by attenuating the electrostatic component of the force 
field using a fixed dielectric constant of 10.0. In addition, the non-bonded cutoff distance 
was set to a value of 999.0 A - a greatly exaggerated value compared to the fully-
extended length of the peptide - in order to create a situation where there is effectively no 
cutoff for the non-bonded interactions. However, energy minimization was now done 
using CHARMm 31.1 molecular modeling software71 instead of NAMD 2.6, because the 
structural constraints that needed to be implemented (see below) were unavailable in 
NAMD. Minimization was executed on an 800 MHz SGI Tezro computer at Brock 
University. 
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The first part of the minimization process required optimizing the alignment of 
the four ~-strands with one another. To do so, one-way harmonic distance constraints 
were imposed between pairs of peptide bonds expected to form the backbone-backbone 
hydrogen bonds within the antiparallel ~-sheet structure, with particular attention paid to 
the central seven residues of each polyQ segment - i.e. the residues predicted to give rise 
to the ~-strands of PGQ9.26 For each expected hydrogen bond, a distance constraint was 
imposed between the interacting amide hydrogen and amide oxygen (using the 
RESDistance tool of CHARMm), and was set up such that a potential energy penalty 
would only be applied if the distance between the interacting atoms exceeded an allowed 
cutoff value. A large force constant of 10.0 kcalimol·A2, and a generous cutoff of 3.0 A, 
were applied such that the constraint would guide and hold the interacting atoms close to 
one another, while final assembly of the hydrogen bond (which is expected to occur at 
hydrogen-oxygen distances <3.0 A93) would be carried out solely by the normal van der 
Waals and electrostatic potential energies of the CHARMm force field. Minimization 
was then performed for 1000 steps using CHARMm's adopted-basis Newton-Raphson 
(ABNR) algorithm. 
The second part of the minimization process required aligning the glutamine side 
chains of the four ~-strands in order to establish the side chain-side chain hydrogen bonds 
implicated in the ~-sheet polar zipper (see Section 1.2). Amide hydrogen-amide oxygen 
distance constraints were imposed between side-chain amide groups from neighbouring 
strands following the protocol described above, with particular attention once again paid 
to the central seven residues of each polyQ segment. Then, a further 1000 steps of 
ABNR minimization were performed, resulting in a final energy gradient of <0.1 
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kcallmol·A. Finally, the presence of p-sheet structure after minimization (see Figure 17) 
was confirmed by examination with VMD 1.8.4 molecular viewing software/5 prior to 
continuing with simulation of the structure. 
Figure 17: Stick model illustration of the generated antiparallel p-sheet structure of 
PGQ9, after completion of initial energy minimization (image generated using Swiss-
PdbViewer 3.7 94 ). The polyglutamine segments are highlighted in orange, and the 
proline-glycine amino acid residue pairs are highlighted in blue and white (blue=proline, 
white=glycine). For clarity, the amino acid side chains have been omitted, and residues 
at the ends of each polyglutamine segment are labeled according to their numbers in the 
amino acid sequence. 
Upon completion of the minimization process, the constraints were released, and 
the antiparallel p-sheet structure was then subjected to a low-temperature MD simulation 
- using the same low temperature implemented during SA-MD (see Section 2.1.3) - in 
order to generate an ensemble of related structures for examination. As with the 
minimization, the simulation was performed using CHARMm 31.1,71 and executed on an 
800 MHz SGI Tezro computer at Brock University. The CHARMm22 force field72 was 
implemented, with a non-bonded cutoff distance of 999.0 A, and solvent effects were 
represented by attenuating the electrostatic component of the force field using a fixed 
dielectric constant of 10.0. A time step of 1.0 fs was implemented throughout the 
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simulation, and all covalent bonds to hydrogen atoms were constrained using the SHAKE 
algorithm.8o During the simulation, the minimized ~-sheet structure was heated linearly 
from 0 K to 50 Kover 5.0 ps (velocity reassignment protocol), and then simulated at 50 
K (NVE ensemble; velocity rescaling protocol) for 50 ps. During constant-temperature 
simulation, the structure of the peptide was saved every 1.0 ps, thus yielding a set of 50 
antiparallel ~-sheet structures for subsequent analysis. However, before proceeding with 
the subsequent analysis, the presence of ~-sheet structure within the saved structures was 
confirmed by examination with VMD 1.8.4.75 
2.5.3. Antiparallel fJ-Sheet Structures: Structure Analysis 
The generated antiparallel ~-sheet structures of PGQ9 were subjected to a DSSP-
based local secondary structure analysis, an analysis of in-register contacts, and analysis 
of potential energies via CHARMm22 molecular mechanics energy calculations. The 
analyses were done following the same protocols implemented for the non-constrained 
SA-MD structures of PGQ9 (see Section 2.5.1). It should be noted that although the 
anti parallel ~-sheet structures generated by CHARMm 31.1 were produced using the 
same CHARMm22 force field72 implemented in NAMD,73 the final energy minimization 
and calculations were performed using the conjugate gradient algorithm of NAMD to 
ensure consistency with the final calculated energies of the SA-MD-generated structures. 
Finally, the structural and potential energy results obtained for the antiparallel ~­
sheet structures of PGQ9 were plotted as frequency histograms, alongside the respective 
results for both sets of PGQ9 structures that were generated by SA-MD (Sections 2.1 and 
2.5.1). All graphs were generated using Origin 7.5 graphing software,86 and the results 
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for the three sets of structures were plotted together to permit comparison of the three 
structure sets (see Figures 18-22). 
3. RESULTS AND DISCUSSION 
3.1. Comparison of PGQ9 Constrained SA-MD Structures with 
Non-Constrained SA-MD Structure and Antiparallel ~-Sheet 
Structure Controls 
3.1.1. Comparison of Molecular Mechanics Potential Energies 
Upon examination of the computed CHARMm22 molecular mechanics potential 
energies for the three sets of PGQ9 structures (see Figure 18), it was found that the 
bonded and non-bonded potential energies of the structures generated by SA-MD 
simulations with constraints (Section 2.1) were crowded considerably closer to those of 
the antiparallel ~-sheet structures (Section 2.5.2) than were the energies of the structures 
generated by SA-MD simulations without constraints (Section 2.5.1). Therefore, from an 
energetic standpoint, the constraints appear to have pushed the PGQ9 peptide closer to 
antiparallel ~-sheet structure, thereby fulfilling the expected effect of enhancing tendency 
toward ~-structure. Still, the energies of the constrained SA-MD structures were 
generally lower in value than those of the antiparallel ~-sheet structures. Therefore, 
assuming that the generated antiparallel ~-sheet structures are reasonably close to those 
that would be formed upon aggregation, the SA-MD simulations with constraints located 
PGQ9 structures lower in energy than ~-sheet structure, and thus appear to have fulfilled 
the purpose of generating low-energy structures of the peptide. 
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Figure 18: Frequency histograms of CHARMm22 molecular mechanics total potential 
energies of the three structure sets generated for PGQ9- The potential energy value (in 
kcallmol) is plotted along the horizontal axis, and the number of peptide structures (out of 
each structure set) exhibiting each energy value is plotted along the vertical axis. Red = 
non-constrained SA-MD structures of PGQ9 (Section 2.5.1); green = constrained SA-MD 
structures of PGQ9 (Section 2.1); blue = antiparallel ~-sheet structures of PGQ9 (Section 
2.5.2). (a) Bonded energies (Equation 2, Section 2.3.1); (b) non-bonded energies 
(Equation 3, Section 2.3.1). 
More notably, by shifting the potential energy tendencies in stronger favour of 
anti parallel ~-sheet structure, an overall shift of bonded (geometric) potential energies 
toward higher values and non-bonded potential energies toward lower values was 
incurred, compared to the SA-MD structures generated without constraints (see Figure 
18). Therefore, assuming that the generated anti parallel ~-sheet structures are reasonably 
close to those that would be formed upon aggregation, conformational effects appear 
likely to be a major limiting factor in the unfavourable transition toward ~-sheet structure 
during aggregation. Indeed, a closer examination of the major components of bonded 
energy (see Equation 2) for the three structure sets indicated that the vast majority of the 
bonded energy deviation between the structure sets was due to differences in dihedral 
energy (see Figure 19). This observation fits the trend of energy difference magnitudes 
that would be expected from the CHARMm22 potential energy function in the case of 
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physically-relevant conformational differences between structure sets for a single peptide, 
and is thus consistent with a conformational difference between the three structure sets. 
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Figure 19: Frequency histograms of CHARMm22 molecular mechanics bonded energy 
components (see Equation 2) of the three structure sets generated for PGQ9. The 
potential energy value (in kcal/mol) is plotted along the horizontal axis, and the number 
of peptide structures (out of each structure set) exhibiting each energy value is plotted 
along the vertical axis. Red = non-constrained SA-MD structures of PGQ9 (Section 
2.5.1); green = constrained SA-MD structures ofPGQ9(Section 2.1); blue = antiparallel 
~-sheet structures of PGQ9 (Section 2.5 .2). (a) Bond-stretching energies; (b) bond-angle-
bending energies; (c) dihedral energies; (d) improper dihedral energies. 
In addition, a calculation of dihedral energies excluding the three tum-forming 
regions of PGQ9 (i.e. residues 9-12, 20-23 and 31-34) indicated that the observed 
differences in dihedral energy were due entirely to differences within the four ~-strand-
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forming segments of PGQ9 (see Figure 20a), and a further calculation on only the 
backbone atoms of the ~-strand-forming segments indicated that the energy differences 
were localized to the peptide backbones of these segments (see Figure 20b). Therefore, 
the large difference in dihedral energy exhibited by the anti parallel ~-sheet structures is 
not due to introduction of the non-standard tum between the two central strands, and so 
such a tum must indeed be energetically compatible with the peptide. Also, assuming 
that the generated antiparallel ~-sheet structures are reasonably close to those that would 
be formed upon aggregation, it would appear that ~-strand structure is conformationally-
disfavoured in the case of polyQ peptides - an observation that is indeed compatible with 
the experimentally-observed thermodynamic penalty associated with polyQ aggregate 
nucleation (as described in Section 1.2).47 Thus, conformational perturbations favouring 
a native preference for coil structure should further discourage the ~-sheet transition as 
was hypothesized, thereby inhibiting aggregation of the peptide. 
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Figure 20: Frequency histograms of CHARMm22 molecular mechanics dihedral 
potential energies of the three structure sets generated for PGQ9. The potential energy 
value (in kcal/mol) is plotted along the horizontal axis, and the number of peptide 
structures (out of each structure set) exhibiting each energy value is plotted along the 
vertical axis. Red = non-constrained SA-MD structures of PGQ9 (Section 2.5.1); green = 
constrained SA-MD structures of PGQ9 (Section 2.1); blue = antiparallel ~-sheet 
structures of PGQ9 (Section 2.5.2). (a) Dihedral energies excluding the three tum-
forming regions of the peptide; (b) dihedral energies excluding the three tum-forming 
regions of the peptide, and only including the backbone atoms of the remaining peptide 
segments. 
3.1.2. Comparison offJ-Sheet Structural Tendency 
Upon examination of the in-register contact counts obtained for the three sets of 
PGQ9 structures (see Figure 21), it became clear that the presence of the applied 
structural constraints resulted in a preference for formation of a number of in-register 
contacts - and thus, an extent of global ~-sheet structure tendency - closer to that of the 
anti parallel ~-sheet structures than when no constraints were used. In addition, a DSSP 
analysis demonstrated a shift in the extent of local ~-structure formation towards that of 
the antiparallel ~-sheet structures in the presence of the applied constraints (see Figure 
22). Therefore, the potential energy perturbation observed upon application of the 
constraints (see Section 3.1.1) was indeed accompanied by a visible shift in structural 
tendency favouring a greater extent of ~-sheet structure formation. 
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Figure 21: Frequency histogram of the occurrence of in-register ~-sheet contacts within 
the three structure sets generated for PGQ9- The number of contacts within the peptide is 
plotted along the horizontal axis, and the number of peptide structures (out of the set of 
500 structures) exhibiting that number of contacts is plotted along the vertical axis. The 
greater the value along the horizontal axis at which the histogram reaches a maximum 
value along the vertical axis, the stronger the measured tendency is for global ~-sheet 
structure formation. Total in-register contact counts across all three pairs of interacting 
polyglutamine segments (outlined in Figure 16) are shown: red = non-constrained SA-
MD structures of PGQ9 (Section 2.5.1); green = constrained SA-MD structures of PGQ9 
(Section 2.1); blue = antiparallel ~-sheet structures of PGQ9 (Section 2.5.2). 
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Figure 22: Frequency histogram of the occurrence of hydrogen-bonded ~-structure 
within the first, second and third polyQ segments of PGQ9, as determined by DSSP 
analysis. The number of residues in the segments in question that exhibited hydrogen-
bonded ~-structure is plotted along the horizontal axis, and the number of peptide 
structures (out of the set of 500 structures) exhibiting that number of residues is plotted 
along the vertical axis. The greater the value along the horizontal axis at which the 
histogram reaches a maximum value along the vertical axis, the stronger the measured 
tendency is for hydrogen-bonded ~-structure. Total residue counts across all three 
segments are shown: red = non-constrained SA-MD structures of PGQ9 (Section 2.5.1); 
green = constrained SA-MD structures of PGQ9 (Section 2.1); blue = antiparallel ~-sheet 
structures ofPGQ9 (Section 2.5.2). 
More notably, the non-constrained structures of PGQ9 exhibited a strong 
preference for formation of no ~-structure at all. Therefore, if the analyzed structures of 
PGQ9, PGQ9(P J) and PGQ9(p2,3) had been generated without the use of structural 
constraints, it was likely that very little (if any) tendency for ~-structure would have been 
observed for any of the peptides. As a result, any differences in ~-structure tendency 
between the peptides would have been more difficult to resolve if the constraints had not 
been used. In addition, it made sense to perform the other analyses of interest on the 
constrained structures as well, in order to ensure consistency in the structures throughout 
the study. Thus, the application of structural constraints to the three peptides during SA-
MD was necessary for the purpose of the current study. 
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Still, the extent of ~-structure formation observed from the SA-MD simulations 
with constraints was rather low, and so any evidence of differences in ~-structure 
tendency between the peptides would have inherently been rather weak. However, if~­
sheet structure is energetically disfavoured - as has indeed been suggested both 
experimentally,47 and computationally with ~-sheet-biased force fields63 - then the low-
energy-structure bias of SA-MD could be expected to yield a low occurrence of ~-sheet 
structure (as was indeed observed). Nevertheless, examination of low-energy structures 
was still likely to yield information that would have been unresolved or overlooked with 
conventional simulation methods, and so application of the method was continued with 
the remaining peptides of interest (producing the results described in the following 
sections). 
3.2. Peptide Comparisons: Local Structure Analysis 
3.2.1. Peptide Backbone Dihedrals 
Examination of the dihedrals exhibited by the three non-constrained polyQ 
segments of PGQ9 (Figure 24), and their constituent individual glutamine residues 
(Figure 25), indicated a strong preference of these residues for PPII-like and a-helix-like 
dihedrals (see Figure 23 for outline of dihedral angle ranges). There was also a tendency 
for other dihedrals, including those consistent with ~-strand structure. However, such 
dihedrals occurred much less frequently than the preferred PPII-like and a-helix-like 
dihedrals, indicating a rather weak inherent tendency for these other dihedrals. 
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Figure 23: Outline of the major dihedral angle ranges examined during backbone 
dihedral analysis of the three peptides: ~-strand-like dihedrals, PPII-like dihedrals, and u-
helix-like dihedrals. The value of the <p-dihedral is plotted along the horizontal axis, and 
the value of the \jf-dihedral is plotted along the vertical axis. For clarity, the boundaries 
of the PPII-like dihedrals range (-105 ° :S <p:S -45°, 120°:S \jf :S 180°)84,95 are indicated by a 
red box. 
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Figure 24: Two-dimensional backbone dihedral frequency histograms for the first, 
second and third polyQ segments of PGQ9. The value of the cp-dihedral is plotted along 
the horizontal axis; the value of the \jf-dihedral is plotted along the vertical axis; and the 
colours plotted on the histogram indicate the frequency of occurrence of each pair of (cp, \jf) 
values in the peptide segment in question. For clarity, the boundaries of the PPII-like 
dihedrals range (-105° :S cp :S -45°, 120° :S \jf :S 180°)84,95 are indicated by a pink box. 
(a) First segment; (b) second segment; (c) third segment. 
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Figure 25: Two-dimensional backbone dihedral frequency histograms for some 
individual glutamine residues from the first, second and third polyQ segments of PGQ9. 
The value of the <p-dihedral is plotted along the horizontal axis; the value of the \11-
dihedral is plotted along the vertical axis; and the colours plotted on the histogram 
indicate the frequency of occurrence of each pair of (<p,\II) values in the residue in 
question_ For clarity, the boundaries of the PPII-like dihedrals range (-105°:S <p:S -45°, 
120° :s \II :s 180°)84,95 are indicated by a pink box_ Residues of the first segment: (a) 
glutamine 3; (b) glutamine 4; (c) glutamine 5 (mutated to proline in PGQ9(pl)); (d) 
glutamine 6. Residues of the second segment: (e) glutamine 14; (f) glutamine 15; (g) 
glutamine 16 (mutated to proline in PGQ9(p2,3)); (h) glutamine 17. Residues of the third 
segment: (i) glutamine 25; (j) glutamine 26; (k) glutamine 27 (mutated to proline in 
PGQ9(p2,3)); (1) glutamine 28_ 
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Figure 25 continued. 
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Figure 25 continued. 
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When the central glutamine residue of the first polyQ segment (in the case of 
PGQ9(pl); residue 5), or the second and third polyQ segments (in the case of PGQ9(p2,3); 
residues 16 and 27), was mutated to proline, the range of dihedrals exhibited by these 
residues became considerably more confined (see Figures 26c and 27c,g; compare to 
Figure 25c,g,k). Now, the dihedrals resided almost entirely within two narrow ranges of 
values - PPII-like dihedrals, and turn-like dihedrals close to the a-helix range - with little 
appreciable tendency for ~-strand-like or other dihedrals. Also, the glutamine residues 
immediately amino-terminal to the mutated residues exhibited confinement in the range 
of values for their 'V-dihedrals, which now resided mostly near values compatible with 
PPII-like structure, although the range of values for the <p-dihedrals appeared to remain 
the same as in PGQ9 (see Figures 26b and 27b,f; compare to Figure 25b,f,j). Therefore, 
as expected, the glutamine~proline mutations introduced in PGQ9(pl) and PGQ9(p2,3) 
induce conformational confinement within the peptide backbone. However, the ranges of 
dihedrals exhibited by all other residues remained the same as in PGQ9, indicating that 
the conformational confinement was highly localized. In addition, the confined ranges of 
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dihedrals exhibited a great degree of similarity with the preferred dihedrals observed in 
PGQ9, thus suggesting that the observed structural confinement is based largely on local 
structural tendencies that are already present prior to introduction of the 
glutamine~proline mutations. 
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Figure 26: Two-dimensional backbone dihedral frequency histograms for some 
individual glutamine/proline residues from the first polyQ segment of PGQ9(p i ). The 
value of the <p-dihedral is plotted along the horizontal axis; the value of the \jf-dihedral is 
plotted along the vertical axis; and the colours plotted on the histogram indicate the 
frequency of occurrence of each pair of (<p,\jf) values in the residue in question. For 
clarity, the boundaries of the PPII-like dihedrals range (-105° :s <p :s -45°, 120° :s \jf :s 
180°)84,95 are indicated by a pink box. (a) Glutamine 3; (b) glutamine 4; (c) proline 5 
(mutated from glutamine to proline); (d) glutamine 6. All other residues exhibit trends 
similar to those in PGQ9. 
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Figure 27: Two-dimensional backbone dihedral frequency histograms for some 
individual glutamine/proline residues from the second and third polyQ segments of 
PGQ9(p2,3). The value of the cp-dihedral is plotted along the horizontal axis; the value of 
the \jf-dihedral is plotted along the vertical axis; and the colours plotted on the histogram 
indicate the frequency of occurrence of each pair of (cp,\jf) values in the residue in 
question. For clarit~, the boundaries of the PPII-like dihedrals range (-105° :S cp:S -45°, 
120° :S \jf :S 180°)84, 5 are indicated by a pink box. Residues of the second segment: (a) 
glutamine 14; (b) glutamine 15; (c) proline 16 (mutated from glutamine to proline); (d) 
glutamine 17. Residues of the third segment: (e) glutamine 25; (t) glutamine 26; (g) 
proline 27 (mutated from glutamine to proline); (h) glutamine 28. All other residues 
exhibit trends similar to those in PGQ9. 
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Figure 27 continued. 
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3.22 Dictionary of Protein Secondary Structure (DSSP) Analysis 
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As with the backbone dihedral analysis, very similar local secondary structure 
preferences were observed from the DSSP analysis of all three peptides, thus further 
suggesting that the glutamine-proline mutations introduced in PGQ9(pl) and PGQ9(p2,3) 
act upon peptide structure based largely on existing local structural tendencies. The 
observed secondary structure tendencies (see Figure 28) included a strong preference for 
the non-hydrogen-bonded secondary structure types - bends and loop/irregular structure 
- over other structure types. In addition, there was a weaker, but appreciable tendency 
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for hydrogen-bonded ~-structure, and very little tendency for hydrogen-bonded turns. 
Finally, there was no visible tendency for 31O-helix, a-helix or n-helix structure, 
indicating that the strong observed tendency for a-helix-like dihedrals was not due to a-
helix-like structures. 
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Figure 28: Frequency histograms of the occurrence of seven types of secondary structure 
within the first, second and third polyQ segments of PGQ9, PGQ9(pl) and PGQ9(p2,3), as 
determined by DSSP analysis. The number of residues in the segments in question that 
exhibited each secondary structure type is plotted along the horizontal axis, and the 
number of peptide structures (out of the set of 500 structures) exhibiting that number of 
residues is plotted along the vertical axis. The greater the value along the horizontal axis 
at which the histogram reaches a maximum value along the vertical axis, the stronger the 
measured tendency is for the respective secondary structure type. Total residue counts 
across all three segments are shown: (a) non-hydrogen-bonded bends; (b) non-hydrogen-
bonded loop/irregular structure (including PPII); (c) hydrogen-bonded ~-structure; (d) 
hydrogen-bonded turns. No tendency for 3 1O-helix, a-helix or n-helix was observed (data 
not shown). Colour key: red = PGQ9; green = PGQ9(pl); blue = PGQ9(p2,3). 
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3.2.3. Summary of Local Structure Results 
Very similar local structure preferences were visible for all three peptides from 
the backbone dihedral and DSSP analyses. First of all, the strong loop/irregular structure 
tendency observed from the DSSP analysis, and the observed tendency for PPII-like 
dihedrals, both indicate a prominent occurrence of PPII-like local structure. In addition, 
the strong bend (and weak hydrogen-bonded turn) tendency observed from the DSSP 
analysis, and the observed tendency for a-helix-like dihedrals, are consistent with a 
prominent occurrence of bend/turn local structure - certain types of which possess 
dihedrals within or near the a-helix range. 84 Finally, the dihedral and DSSP analyses 
both indicated a weak occurrence of local ~-structure. Therefore, all three peptides 
appear to possess a strong preference for PPII and bend/turn local structures, with a 
weaker tendency for ~-structure. 
This local structure tendency is significant for two reasons. First of all, such 
tendency is compatible with a global preference for coil structure, and a less favourable 
tendency for ~-structure. Thus, the results are compatible with the normal structural 
behaviour of polyQ peptides as reported from experiment (see Section 1.2). Secondly, 
PPII and bend/turn structure types are strongly favoured by proline, and are thus 
compatible with the glutamine~proline mutations introduced in PGQ9(pl) and 
PGQ9(p2,3). 
These results, coupled with the localized conformational confinement observed 
from the backbone dihedral analysis, suggest that as hypothesized, the 
glutamine~proline mutations introduced in PGQ9(pl) and PGQ9(p2,3) influence peptide 
structure by means of localized conformational restraint. This restraint confines the 
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peptide backbone to existing local tendencies for aggregation-incompetent PPII and/or 
turn/bend structure, which would in turn tend to increase the global preference for coil 
structure over ~-sheet structure. 
3.3. Peptide Comparisons: Potential Energy Analysis 
3.3.1. Analysis of Molecular Mechanics Potential Energies 
Upon examination of the computed CHARMm22 molecular mechanics bonded 
and non-bonded potential energies for the three peptides, it was found that the non-
bonded energy distributions for all three peptides consistently overlapped. This was true 
in the case of the peptide backbone potential energies (excluding side chains; Figure 29b), 
the potential energies excluding the three mutated residues (Figure 30b), and even for the 
potential energies excluding as little as only the functional groups of the mutated residues 
that are altered by mutation (see Section 2.3.2 for description; Figure 31 b). Thus, it 
appears that any differences in non-bonded energy are limited strictly to the hydrogen-
bonding functional groups that are lost as a direct result of the glutamine~proline 
mutations OfPGQ9(p 1) and PGQ9(p2,3) - i.e. the 8-carbon amide groups and peptide bond 
hydrogen atoms of the mutated glutamine residues (Figure 12). Therefore, the 
conformational samples could not be discriminated from one another on the basis of non-
bonded interactions, and so non-bonded perturbations of peptide structure do not appear 
to be an appreciable effect of the glutamine~proline mutations. 
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Figure 29: Frequency histograms of CHARMm22 molecular mechanics peptide 
backbone potential energies for PGQ9, PGQ9(pl) and PGQ9(p2,3). These energies were 
computed from polyglycine versions of the structures for each peptide, in order to 
exclude energy contributions from the amino acid side chains. The potential energy 
value (in kcallmol) is plotted along the horizontal axis, and the number of peptide 
structures (out of the set of 500 structures) exhibiting each energy value is plotted along 
the vertical axis. Red = PGQ9; green = PGQ9(pl); blue = PGQ9(p2,3). (a) Bonded 
energies (Equation 2, Section 2.3.1); (b) non-bonded energies (Equation 3, Section 2.3.1). 
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Figure 30: Frequency histograms of CHARMm22 molecular mechanics potential 
energies for PGQ9, PGQ9(pl) and PGQ9(p2,3), excluding the central residues of the first, 
second and third polyglutamine segments. The potential energy value (in kcallmol) is 
plotted along the horizontal axis, and the number of peptide structures (out of the set of 
500 structures) exhibiting each energy value is plotted along the vertical axis. Red = 
PGQ9; green = PGQ9(pl); blue = PGQ9(p2,3). (a) Bonded energies (Equation 2, Section 
2.3.1); (b) non-bonded energies (Equation 3, Section 2.3.1). 
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Figure 31: Frequency histograms of CHARMm22 molecular mechanics potential 
energies for PGQ9, PGQ9(pl) and PGQ9(p2,3), excluding the o-carbon functional groups 
and peptide bond hydrogen atoms (see Section 2.3.2) of the central residues of the first, 
second and third polyglutamine segments. The potential energy value (in kcallmol) is 
plotted along the horizontal axis, and the number of peptide structures (out of the set of 
500 structures) exhibiting each energy value is plotted along the vertical axis. Red = 
PGQ9; green = PGQ9(P\ blue = PGQ9(p2,3). (a) Bonded energies (Equation 2, Section 
2.3.1); (b) non-bonded energies (Equation 3, Section 2.3.1). 
The bonded energy distributions for all three peptides, on the other hand, 
consistently deviated from one another, with a clear increase in energy from PGQ9 to 
PGQ9(p1), to PGQ9(p2,3) (see Figures 29a, 30a and 31 a). Indeed, a subsequent 
lonckheere k-sample test (Section 2.3.6) clearly confirmed the presence of significant 
energy differences (see Table 3). The observed ordering of energies correlated with the 
number of glutamine~proline mutations introduced into the polyQ segments of the 
peptides - none for PGQ9, one mutation for PGQ9(p i ) , and two mutations for PGQ9(p2,3) 
(see Table 2) - and was thus not surprising. Since the bonded energies consistently 
deviated when the non-bonded energies did not, it is clear that bonded energy differences 
between the peptides are more prominent than are any non-bonded energy differences. In 
addition, examination of the major components of bonded energy (see Equation 2) 
revealed that although the first three components all exhibited deviations in value 
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between the peptides, dihedral energy was the major contributor to the observed bonded 
energy differences, with a smaller contribution from bond-angle-bending energy and only 
minimal contribution from bond-stretching energy (see Figure 32, for example). This 
observation fits the trend of energy difference magnitudes that would be expected from 
the CHARMm22 potential energy function in the case of physically-relevant 
conformational differences between peptides, and is thus consistent with a 
conformational difference between the structural ensembles for the three peptides. 
Table 3: Results of Jonckheere k-Sample Test for Molecular Mechanics Potential 
EDt nergy aa 
Potential Energy Scalculated Zcalculated a Zcritical a Significant 
Data Set Difference 
Among the 
Three 
Peptides?b 
Backbone Bonded 332142 18.19 2.58 Yes 
(Figure 29a) 
Total Bonded, 505064 27.65 2.58 Yes 
Without Mutated 
Residues 
(Figure 30a) 
Total Bonded, 692510 37.92 2.58 Yes 
Without Mutated 
Functional Groups 
(Figure 31 a) 
Total Local 247742 13.56 2.58 Yes 
Conformational, 
Without Mutated 
Residues 
(Figure 34a) 
aSmce the data sets for each peptIde were so lar~e, the normal approximatlOn was utilized 
for each test (for test details, see Appendix D).9 
b A significant difference exists between the three samples if -Zcritical:S Zcalculated :s Zcritical. 
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Figure 32: Frequency histograms of CHARMm22 molecular mechanics bonded energy 
components (see Equation 2) for PGQ9, PGQ9(pl) and PGQ9(p2,3), excluding the 8-
carbon functional groups and peptide bond hydrogen atoms (see Section 2.3.2) of the 
central residues of the first, second and third polyglutamine segments. The potential 
energy value (in kcallmol) is plotted along the horizontal axis, and the number of peptide 
structures (out of the set of 500 structures) exhibiting each energy value is plotted along 
the vertical axis. Red = PGQ9; green = PGQ9(pl); blue = PGQ9(p2,3). (a) Bond-
stretching energies; (b) bond-angIe-bending energies; (c) dihedral energies; (d) improper 
dihedral energies. Here, the following deviations in energy value are visible between the 
PGQ9 and PGQ9(p2,3) distributions: bond-stretching energy = ~ 1 kcallmol; bond-angle-
bending energy = ~ 10 kcallmol; dihedral energy = ~ 15 kcallmol; improper dihedral 
energy = no visible deviation. 
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These results suggest that m accordance with the hypothesis, the 
glutamine~proline mutations introduced in PGQ9(P I) and PGQ9(p2,3) perturb peptide 
structure primarily by means of local, geometry-based effects, with little appreciable 
contribution from non-bonded effects. 
3.3.2. Analysis of Quantum Mechanical FMO Potential Energies, and Comparison 
With Molecular Mechanics 
Initial examination of the quantum-mechanical potential energies computed based 
on the representative structures of each peptide (Section 2.3.3) seemed to suggest a trend 
due to the small numbers of peptide structures examined in the quantum-mechanical 
energy calculations (see Section 2.3.3 for details), a lonckheere k-sample test (Section 
2.3.6) was performed on the calculated energies of the three peptides to check for 
statistically-significant differences among them. Upon doing so it was found that the 
local conformational energies (Equation 5) of the three peptides differed significantly in 
value, while the long-range non-bonded energies (Equation 6) of the peptides were not 
significantly different after all (see Table 4). 
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Table 4: Results of Jonckheere k-Sample Test for Quantum-Mechanical FMO 
P t f IE D t o en la nergy aa 
Potential Energy Scalculated tcalculated a tcritical a Significant 
Data Set Difference 
Among the 
Three 
Peptides?b 
Total Local 212 3.66 2.65 Yes 
Conformational, 
Without Mutated 
Residues 
(Figure 33a) 
Total Long-Range 130 2.12 2.65 No 
Non-Bonded, 
without Mutated 
Residues 
(Figure 33b) 
Total Local 102 1.64 2.65 No 
Conformational, 
Without Mutated 
and Neighbouring 
Residues 
(Section 3.3.3) 
aSince the data sets for each peptide were small in size (8 structures for PGQ9, 12 
structures for PGQ9(p l), and 14 structures for PGQ9(p2,3)), the Student's t approximation 
was utilized for each test (for test details, see Appendix D).92 
b A significant difference exists between the three samples if -tcritical:S tcalculated :s tcritical. 
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Figure 33: Statistical boxplots of total quantum-mechanical FMO potential energies for 
PGQ9, PGQ9(pl) and PGQ9(p2,3), excluding the central residues of the first, second and 
third polyglutamine segments (plots constructed using Origin 7.5 graphing software86). 
The potential energy value (in kcallmol) is plotted along the vertical axis. The range of 
energy values covered by each peptide is indicated by a box with flanking vertical lines; 
and the 25th percentile, median and 75th percentile energy values are indicated by the 
three horizontal lines of the box. Red = PGQ9 (8 structures); green = PGQ9(pl) (12 
structures); blue = PGQ9(p2,3) (14 structures). (a) Local conformational energies; (b) 
long-range non-bonded energies. 
Upon examination of the analogous molecular mechanics potential energIes 
(Section 2.3.4), it was found that in agreement with the quantum-mechanical energy 
results, the long-range non-bonded energy distributions for all three peptides overlapped 
(see Figure 34b). The molecular mechanics local conformational energies, on the other 
hand, deviated significantly from one another, following a trend similar to that observed 
for the molecular mechanics bonded energies (see Figure 34a and Table 3). Therefore, 
the quantum mechanical FMO and molecular mechanics potential energy calculations 
both indicate that the energy differences between the peptides are primarily local-
conformational in nature, with little appreciable long-range non-bonded contribution. 
Thus, the occurrence of potential energy differences between the peptides as determined 
by molecular mechanics is consistent with what quantum mechanics would indicate, 
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confirming that the conclusions drawn from the molecular mechanics potential energy 
results must indeed be valid. 
(a) 
~ 
c: 
Q) 
::> 
80 
60 
~ 40 
u.. 
20 
O~"--"-I' __ -
40 50 60 
Energy (kcal/mol) 
70 80 
(b) 
100 
80 
>-g 60 
Q) 
::> 
0" 
i" 
u.. 40 
20 
o 
-250 -240 -230 -220 -210 -200 -190 -180 
Energy (kcal/mol) 
Figure 34: Frequency histograms of total molecular mechanics FMO-analogue potential 
energies (Section 2.3.4) for PGQ9, PGQ9(pl) and PGQ9(p2,3), excluding the central 
residues of the first, second and third polyglutamine segments. The potential energy 
value (in kcal/mol) is plotted along the horizontal axis, and the number of peptide 
structures (out of the set of 500 structures) exhibiting each energy value is plotted along 
the vertical axis. Red = PGQ9; green = PGQ9(pl); blue = PGQ9(p2,3). (a) Local 
conformational energies; (b) long-range non-bonded energies. 
3.3.3. Molecular Mechanics Total Potential Energies: Further Analysis 
Upon examination of the final sets of computed molecular mechanics and 
quantum mechanical FMO energies, it was found that the bonded and local 
conformational energy distributions for all three peptides overlapped (see Figures 35 and 
36, and Table 4) - in contrast to the results from the preceding energy calculations. 
Therefore, while the differences between the peptides have proven to be due primarily to 
local, geometry-based effects, as reflected by the previously-observed inter-peptide 
differences in bonded/local conformational potential energies (Sections 3.3.1 and 3.3.2), 
the effects are still quite localized in nature. In particular, the final energy calculations 
confirm that the differences in bonded/local conformational potential energies between 
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the peptides are confined to the central amino acid residues of the first, second and third 
polyQ segments, and the residues immediately amino-terminal to the central residues -
the same residues whose local structure tendencies were affected by the 
glutamine~proline mutations introduced in PGQ9(pl) and PGQ9(p2,3), as observed from 
the peptide backbone dihedrals analysis (see Section 3.2.1). Therefore, the local structure 
analysis and potential energy calculations both confirm that the glutamine~proline 
mutations of PGQ9(pl) and PGQ9(p2,3) exert a localized conformational effect on the 
structures of the peptides. 
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Figure 35: Frequency histograms of molecular mechanics total bonded energies for 
PGQ9, PGQ9(pl) and PGQ9(p2,3), excluding the central residues of the first, second and 
third polyglutamine segments, and the residues immediately amino-terminal to the central 
residues. The potential energy value (in kcal/mol) is plotted along the horizontal axis, 
and the number of peptide structures (out of the set of 500 structures) exhibiting each 
energy value is plotted along the vertical axis. Red = PGQ9; green = PGQ9(pl); blue = 
PGQ9(p2,3). 
is 
c 
Q) 
::J 
0-
~ 
LL 
100 
80 
60 
40 
20 
40 45 50 55 60 65 70 75 80 
Energy (kcal/mol) 
80 
Figure 36: Frequency histograms of molecular mechanics total local conformational 
energies for PGQ9, PGQ9(pl) and PGQ9(p2,3), excluding the central residues of the first, 
second and third polyglutamine segments, and the residues immediately amino-terminal 
to the central residues. The potential energy value (in kcal/mol) is plotted along the 
horizontal axis, and the number of peptide structures (out of the set of 500 structures) 
exhibiting each energy value is plotted along the vertical axis. Red = PGQ9; green = 
PGQ9(pl); blue = PGQ9(p2,3). 
3.4. Peptide Comparisons: Global Structure Analysis 
3.4.1. Automated Histogram Filtering (AHF) Cluster Analysis 
Upon examination of the trends in number of identified clusters for the AHF 
analysis of inter-a-carbon distances including the carboxy-terminus (Section 2.4.1), it 
was found that the three peptides demonstrated somewhat different rates of increase in 
the number of identified clusters with decreasing peak distinction value (see Figure 37). 
The number of clusters identified for PGQ9 did not begin to rise sharply until a peak 
distinction value of 3 had been reached, while the numbers of clusters identified for 
PGQ9(P I) and PGQ9(p2,3) began to rise sharply somewhat sooner than PGQ9, at a peak 
distinction value of 4. In addition, the number of clusters identified for PGQ9(p2,3) began 
to increase above one at a peak distinction value approximately 50% higher than did 
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PGQ9 or PGQ9(p 1). Therefore, the global structure behaviours of the three peptides could 
be distinguished from one another in terms of structural variation. 
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Figure 37: Plots of the number of clusters of related structures identified by AHF 
analysis, versus the numerical value of the peak distinction parameter employed in the 
analysis. All amino acid residues of each peptide were included in the analysis. Blue 
line = PGQ9; red line = PGQ9(pl); green line = PGQ9(p2,3). 
Upon examination of the trends in number of identified clusters for the AHF 
analysis of inter-a-carbon distances excluding the carboxy-terminus, it was found that the 
PGQ9 and PGQ9(pl) peptides only ever yielded one cluster of structures each (see Figure 
38). The PGQ9(p2,3) peptide, on the other hand, demonstrated a rapid increase in the 
number of identified clusters with decreasing peak distinction value, starting at a peak 
distinction value of 6. Therefore, the global structure behaviour of PGQ9(p2,3) could be 
greatly distinguished from that of PGQ9 and PGQ9(pl) in terms of structural variation -
an extent of difference that was hinted at by the fact that when the carboxy-terminus was 
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included, the number of clusters identified for PGQ9(p2,3) began to increase above one at 
a peak distinction value appreciably higher than for PGQ9 or PGQ9(P'). Thus, the global 
structural variation of PGQ9(p2,3) proved to be very different from that of the other two 
peptides, and only minor differences appeared to exist between PGQ9 and PGQ9(P'). 
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Figure 38: Plots of the number of clusters of related structures identified by AHF 
analysis, versus the numerical value of the peak distinction parameter employed in the 
analysis. The amino acid residues of the carboxy-terminal end of each peptide - which 
was structurally-constrained during the SA-MD simulations - were excluded from the 
analysis, to permit examination of only the portion of the peptide whose structure was 
free to vary during the simulations. Blue line = PGQ9; red line = PGQ9(P'); green line = 
PGQ9(p2,3). 
Examination of the RMSD results for all three peptides (Section 2.4.1) revealed 
that the three peptides gave nearly identical distributions of RMSD values between 
structures (see Figure 39). Therefore, the differences in structural variation observed 
among the peptides (as described above) appear to be attributable to the structure 
clustering situation outlined in Section 2.4.1 and Figure 15 - i. e. a greater rate of increase 
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in the number of clusters with decreasing peak distinction being attributable to greater 
discontinuity in the range of possible global structures. 
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Figure 39: Frequency histograms of inter-a-carbon distance RMSDs computed for PGQ9, 
PGQ9(pl) and PGQ9(p2,3). The RMSD value (in A) is plotted along the horizontal axis, 
and the number of peptide structure pairs exhibiting each RMSD value is plotted along 
the vertical axis. Red = PGQ9; green = PGQ9(pl); blue = PGQ9(p2,3). (a) Calculated 
RMSD values across all amino acid residues; (b) calculated RMSD values excluding the 
amino acid residues of each peptide's carboxy-terminal end. 
According to the above results, PGQ9(p2,3) demonstrates a substantially reduced 
range of possible global structures compared to the other two peptides, while PGQ9(pl) 
demonstrates only a marginally reduced range of possible global structures compared to 
PGQ9. Therefore, it is reasonable to infer that PGQ9(p2,3) exhibits substantially greater 
global structural rigidity than the other two peptides, while PGQ9(pl) exhibits only 
marginally greater global structural rigidity than PGQ9. 
3.4.2. In-Register Contacts: Assessment olGlobal {J-Sheet Tendency 
Upon examination of the in-register contact counts for the three peptides, 
PGQ9(p2,3) demonstrated evidence of a significant shift toward formation of fewer in-
register contacts - and thus, a lesser extent of global ~-sheet structure tendency -
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compared to PGQ9 and PGQ9(pl) (see Figure 40 and Table 5). Indeed, visual 
examination of the structures of each peptide (see Appendix A, for example) revealed 
structures resembling two- or three-stranded sheets in the case of PGQ9 and PGQ9(P I), 
but poor tendency for even two-stranded structures in the case of PGQ9(p2,3). Thus, the 
visually-observed extent of difference between the peptides was, to a certain extent, in 
agreement with the extent of difference observed from the in-register contacts analysis -
thereby validating the use of the method. 
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Figure 40: Fre~uency histograms of the occurrence of in-register ~-sheet contacts within 
PGQ9, PGQ9(P ) and PGQ9(p2,3). The number of contacts within the peptide is plotted 
along the horizontal axis, and the number of peptide structures (out of the set of 500 
structures) exhibiting that number of contacts is plotted along the vertical axis. The 
greater the value along the horizontal axis at which the histogram reaches a maximum 
value along the vertical axis, the stronger the measured tendency is for global ~-sheet 
structure formation. Total in-register contact counts across all three pairs of interacting 
polyglutamine segments (outlined in Figure 16) are shown: red = PGQ9; green = 
PGQ9(pl); blue = PGQ9(p2,3). 
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Table 5: Results of Two-Sample Z-Tests for Differences in Numbers of 
In-Register p-Sheet Contacts 
Peptide Pair Zcalculated Zcritical a Significant 
Difference Between 
The Two 
Peptides?b 
PGQ9 and PGQ9(P I) 1.90 2.58 No 
PGQ9 and PGQ9(p2,J) 10.37 2.58 Yes 
PGQ9(P I) and 7.95 2.58 Yes 
PGQ9(p2,3) 
aThe test was performed at the 1 % significance (99% confidence) level, in two-tailed 
format. 
b A significant difference exists if -Zcritical:S Zcalculated :s Zcritical. 
These results are interesting for two reasons. First of all, PGQ9(p2,3) was the 
peptide that failed to aggregate experimentally, while PGQ9 and PGQ9(pl) both 
successfully aggregated - although at different rates.26 Thus, the observed differences in 
global ~-sheet structure tendency appear to be consistent with the differences in 
aggregation behaviour of the three peptides, further supporting the idea that disruption of 
monomeric ~-sheet structure propensity may be responsible for the observed inhibitory 
effect on aggregation (as discussed in Section 1.5). Secondly, PGQ9(p2,3) demonstrated 
what appeared to be a likely tendency toward greater global structure rigidity than the 
other two peptides (see Section 3.4.1). Therefore, it is reasonable to infer from the results 
that increased global structure rigidity may result in a decreased global ~-sheet structure 
propensity, thereby triggering the experimentally-observed inhibition of peptide 
aggregation. 
However, very few in-register contacts were generally identified in the structures 
obtained by SA-MD, and so the quantitative evidence of differences in ~-sheet propensity 
was still rather weak (as predicted for the SA-MD methodology; see Section 3.1.2). 
Therefore, further simulation work would be warranted in the future to more thoroughly 
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evaluate the ~-sheet tendencies of the three peptides, and the extent to which these 
tendencies differ among the peptides. 
4. SUMMARY AND CONCLUSIONS 
4.1 . Concluding Remarks 
Regarding the mutated variants of Thakur and Wetzel's aggregation-prone PGQ9 
peptide, it was hypothesized that the additional proline mutations within the PGQ9 
variants (see Table 1) exert localized conformational restraint on the peptide backbone, 
confining the backbone to an existing conformational tendency for polyproline type II 
(PPII) and/or turn/bend structure (see Section 1.5). It was also hypothesized that such 
restraint would in turn tend to confine the peptides to a native global preference for coil 
structure over ~-sheet structure, discouraging the already-unfavourable transition towards 
the ~-sheet structure required for aggregate nucleation/growth. To investigate this 
hypothesis, the structural propensities of three of Thakur and Wetzel's peptides - PGQ9, 
PGQ9(pl) and PGQ9(p2,3) - were examined, with emphasis on low-energy structures of 
the peptides. 
Control analyses performed on the PGQ9 peptide suggested that, in agreement 
with experimental studies of polyglutamine aggregation, transition of the peptide 
monomer toward ~-sheet structure is conformationally-disfavoured. In particular, 
formation of ~-strand structure within the peptide backbone of the four polyQ segments 
of PGQ9 was shown to be the source of the observed conformational destabilization. 
Therefore, the structural data utilized in the current study appears to be in line with the 
experimentally-determined idea of an unfavourable transition (from native coil structure 
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to abnormal ~-sheet structure) during polyQ aggregate nucleation. Thus, conformational 
perturbations favouring a native preference for coil structure should indeed discourage 
the ~-sheet transition as was hypothesized, thereby inhibiting aggregation of the peptide. 
Examination of the local secondary structure tendencies exhibited by structures of 
all three selected peptides revealed evidence that the glutamine---+proline mutations 
introduced in PGQ9(pl) and PGQ9(p2,3) exert localized conformational restraint that 
confines the peptide backbone to existing local tendencies for aggregation-incompetent 
PPII and/or turn/bend structure - which would in turn tend to increase the global 
preference for coil structure over ~-sheet structure. In addition, the potential energy 
calculations confirmed that the glutamine---+proline mutations exert a localized 
conformational effect on the structures of the peptides, and ruled out the alternative 
possibility of appreciable non-bonded perturbations - i. e. beyond the inherent loss of 
hydrogen-bonding functional groups incurred by the glutamine---+proline mutations -
which is also possible with proline mutations. Therefore, as hypothesized, the 
glutamine---+proline mutations of PGQ9(P 1) and PGQ9(p2,3) exert a localized primary 
perturbation of peptide structure based on conformational confinement of the peptide 
backbone to an existing tendency for PPII and/or turn/bend structure, which would in 
turn tend to increase the global preference for coil structure over ~-sheet structure. 
Subsequent analysis of the global structural tendencies of the peptides indicated a 
difference in the range of possible global structures, with PGQ9(p2,3) exhibiting a 
substantially reduced range of possible global structures compared to the other two 
peptides. In addition, PGQ9(p2,3) demonstrated weak evidence of a lesser extent of global 
~-sheet structure tendency than PGQ9 or PGQ9(P 1) - a result that coincided with the 
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reduced range of global structures observed for PGQ9(p2,3), as well as the failure of 
PGQ9(p2,3) to aggregate experimentally when PGQ9 and PGQ9(pl) both aggregated?6 
Therefore, the localized primary perturbation of peptide structure exerted by the 
glutamine~proline mutations appears to trigger a secondary, entropic perturbation of 
global peptide structure, discouraging random conformational fluctuations which may be 
involved in the unfavourable transition towards p-sheet structure,47,64,65 and so confining 
the global structure to an existing preference for the coil state. Indeed, introduction of 
such mutations into the polyQ segments of PGQ9 would result in mutant polyQ 
sequences containing glutamine/proline-rich regions, in which intervals of only four or 
five residues separate consecutive prolines (see Table 2). Thus, the affected portion of 
the peptide would become too rigid to make the transition from coil structure to p-sheet 
structure, and as a result, the glutamine~proline mutations should inhibit p-sheet 
assembly while favouring the coil structure state. 
It should be noted, however, that the global perturbation relative to PGQ9 was 
particularly prominent in the case of PGQ9(p2,3), with little perturbation in the case of 
PGQ9(P 1). Thus, the localized primary effect of the glutamine~proline mutations 
appears to trigger an appreciable secondary effect most strongly if central polyQ 
segments of the PGQ9 sequence become affected by the mutations - as is the case with 
PGQ9(p2,3). This finding is not surprising, as it is consistent with the rigidity introduced 
by the terminal segment mutation of PGQ9(P 1) remaining confined to the end of the 
peptide, with flexibility in the rest of the peptide remaining unaffected. Consequently, 
the rest of the peptide would remain flexible enough to make the transition to p-sheet 
structure with minimal hindrance. Also, subsequent monomer-monomer associations 
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would require structural rearrangement of only a small part of the peptide - i. e. the 
affected end - which could be achieved with little difficulty, thus explaining this 
peptide's retention of aggregation propensity (see Figure 41). However, this additional 
folding step would tend to slow down the overall ~-sheet assembly process, thus 
explaining the slower observed aggregation rate for PGQ9(pl) compared to PGQ9 (see 
Figure 9),z6 
(a) (b) (c) 
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Figure 41: Peptide folding considerations in the aggregation of PGQ9(P I). Confinement 
of added rigidity to the amino-terminal end of the peptide leaves the peptide flexible 
enough to arrange itself into ~-sheet structure ( a), and then fold so as to place the affected 
end of the peptide out of the way of subsequent monomer-monomer associations (b-c), 
thereby allowing aggregation to proceed despite the added rigidity. Hydrogen bond 
formation is illustrated by blue dotted lines, and for clarity, the amino terminus of each 
peptide is marked by an "N". 
On the other hand, if the mutations are introduced into the middle of the peptide, 
then the resulting rigidity will affect a more substantial fraction of the peptide - as is 
indeed reflected by the observed global structure differences between peptides. As a 
result, structural rearrangements required to accommodate the peptide's mutations into 
stable ~-sheet structure can no longer be readily achieved, as this would require 
90 
substantial unfolding, and thus an unfavourable extent of intramolecular hydrogen bond 
breakage. Therefore, a stable structure suitable for aggregate nucleation cannot be 
established, explaining the observed altogether-lack of aggregation for peptides such as 
PGQ9(p2,3) (see Figure 9)?6 
This would not be the first time that the idea of introducing localized 
conformational confinement to trigger an inhibition of aggregation has been proposed for 
an amyloidogenic peptide. Indeed, in a recent experimental study of ~-amyloid by 
Kapurniotu et al. (2003),96 a covalent constraint was applied to the middle of the ~­
amyloid peptide A~(1-28), resulting in the direct confinement of the middle of the 
peptide to its native a-helix structure. Such localized constraint of the middle of the 
peptide to its existing structural tendency effectively abolished aggregation, indicating an 
underlying disruption of propensity for the ~-sheet aggregate structure. Therefore, the 
results of this study follow the same basic premise as those of the current study, reaching 
the conclusion that local conformational confinement favouring native global structure 
can inhibit global transition towards abnormal ~-sheet structure, inhibiting amyloidogenic 
aggregation of the peptide in question. Thus, in designing PGQ9(p2,3) and other non-
aggregating peptides, Thakur and Wetzel (2002) appear to have incorporated this very 
idea for inhibiting polyglutamine aggregation. However, designing confinement to coil 
structure in a rational manner is not as easy as designing confinement to ordered 
secondary structure (as was done by Kapumiotu et al.), and so the fact that such an idea 
for native coil structure appears to have been previously overlooked is not surprising. 
Besides inhibition of the peptide' s own aggregation, confinement to coil structure 
would also permit peptides such as PGQ9(p2,3) to act in trans as inhibitors of the growth 
91 
of existing polyQ oligomers/fibrils, and thus protect against cytotoxicity of such polyQ 
species - an inhibition and protection that were indeed observed in later experiments by 
Thakur et al. (2004).97 In this mechanism, the PGQ9(p2,3) would bind to the end of the 
growing oligomer/fibril via polar-zipper interaction (see Section 1.2) of one of its non-
mutated, terminal polyQ segments with the end of the oligomer/fibril ~-sheet structure. 
However, the inherent conformational confinement would trap the remainder of the 
peptide in a coil conformation, effectively creating a constrained-coil cap on the end of 
the oligomer/fibril ~-sheet structure, and preventing further aggregate growth by blocking 
~-strand addition to the end of the ~-sheet (see Figure 42). Therefore, polyQ aggregation 
inhibitors based on peptide conformational confinement are a very possible means of 
inhibiting polyQ aggregation, and development of such rational inhibitors could pave the 
way for effective future treatments of Huntington's and other diseases associated with 
polyQ aggregation. 
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(a) 
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Figure 42: Inhibition of polyglutamine aggregate growth by bound PGQ9(p2,3). 
Although it could easily interact with either end of the aggregate via binding of one of its 
non-mutated, terminal polyglutamine segments, the remainder of the peptide remains 
entrapped in the coil structure state (a). Consequently, the peptide cannot fully make the 
transition to ~-sheet structure (b), which would otherwise provide an exposed ~-strand as 
the necessary site for binding of further ~-sheet subunits to the aggregate. 
4.2. Limitations and Future Work 
As with any computational study, the current study has its limitations. For 
instance, due to the approximation of solvent effects using a fixed dielectric constant, 
interactions of the peptide with the solvent may not have been optimally represented. 
Thus, conclusions drawn from the study are necessarily qualitative in nature. In addition, 
the evidence of differences in ~-sheet propensity that was obtained from the current study 
was rather weak. Therefore, further simulation work would be warranted in the future to 
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more thoroughly evaluate the ~-sheet tendencies of the three peptides, and the extent to 
which these tendencies differ among the peptides. Finally, the anti parallel ~-hairpin tum 
structures implemented in this study were all selected based on educated estimates, as the 
precise structure is not known with absolute certainty. Nevertheless, the results have 
proven to be congruent in several attributes with previously reported data, and so as 
described above (Section 4.1), the current study highlights some key ideas for 
consideration in the future design of effective treatments for Huntington's and other 
polyQ-associated diseases. 
In the future, it may be desirable to perform further simulation work to more 
thoroughly evaluate the structural tendencies of the three peptides, and any differences in 
these tendencies among the peptides. Also, it would be desirable to perform the analyses 
of the current study on the other non-aggregating mutant variants of PGQ9 that were 
examined by Thakur and Wetzel (2002; see Table 1),26 in order to confirm whether 
similar patterns of structural perturbation exist within these peptides as well as 
PGQ9(p2,3). Finally, it would be interesting to extend the study to analysis of each mutant 
peptide bound to the end of a preformed anti parallel ~-sheet monomer or oligomer 
(simulating an existing polyQ aggregate), in order to further confirm the proposal 
regarding inhibition of further aggregate growth by these peptides (as described in Figure 
42, and the end of Section 4.1). 
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APPENDIX A: Stick Model Diagrams of the Representative Peptide 
Structures Selected for Analysis by Quantum-Mechanical 
Fragment Molecular Orbital (FMO) Calculations 
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Note: The structures shown here were selected using automated histogram filtering 
(AHF) cluster analysis (as described in Section 2.3.3 of the thesis). For all structures 
shown, glutamine residues are highlighted in orange, proline residues are highlighted in 
blue, glycine residues are highlighted in white, and residues at the ends of the 
polyglutamine segments are labeled (for clarity) according to their numbers in the amino 
acid sequence. 
(a) Representative Structures of PGQ9 
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(b) Representative Structures of PGQ9(pl) 
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(c) Representative Structures of PGQ9(p2,3) 
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APPENDIX B: Background on CHARMm Force Field 
The CHARMm force field is a force field used in the simulation of macromolecules. It 
represents macromolecules as a series of beads (representing atoms) connected by springs 
(representing bonds), and is computed based on the following potential energy function: 
Ebonded = Ebond + Eangle + Edihedral + Eimproper (B 1) 
Enon-bonded = E VDW + Eelectrostatic (B2) 
Etotaf = Ebonded + Enon-bonded (B3) 
The six energy terms Ebond, Eangle, EdihedraI, Eimproper, EyDW and Eelectrostatic are the total 
bond-stretching, bond-angIe-bending, dihedral (bond rotation), improper dihedral, van 
der Waals and electrostatic energies, respectively. They are computed as follows: 
(B4) 
describes bond-stretching potentials as positive harmonic functions centered around 
equilibrium bond lengths. Here, bi is the current length of a given bond within the 
molecule; bo,i is the equilibrium length of that type of bond; kb,i is a force constant used to 
constrain the bond near its equilibrium length; and the sum is computed over all bonds 
within the molecule. 
(BS) 
describes bond-angIe-bending potentials as positive harmonic functions centered around 
equilibrium bond angle values. Here, 8i is the current value of a given bond angle within 
the molecule; 80,i is the equilibrium value of that type of bond angle; ke,i is a force 
constant used to constrain the bond angle near its equilibrium value; and the sum is 
computed over all bond angles within the molecule. 
Ndihedrals 
Edihedral = ~[k</>I'i(COS(¢i -¢l';))+ k</>2,;Ccos(2¢i -¢2,;))+k</>3,i(cos(3¢i -¢3,i))] (B6) 
describes dihedral potentials as positive cosine functions, with energy minima centered 
around sterically-preferred dihedral values. Here, <Pi is the current value of a given 
dihedral angle within the molecule; <Pl,i, <P2,i and <P3 ,i are constants corresponding to the 
preferred values for that type of dihedral angle; k<j>l ,i, k<j>2,i and k<j>3,i are force constants used 
to bias the dihedral angle toward its preferred values; and the sum is computed over all 
dihedral angles within the molecule. 
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(B7) 
describes improper dihedral potentials as positive harmonic functions centered around 
equilibrium improper dihedral values. Here, (J)i is the current value of a given improper 
dihedral within the molecule; (J)O,i is the equilibrium value of that type of improper 
dihedral; kw,i is a force constant used to constrain the improper dihedral near its 
equilibrium value; and the sum is computed over all improper dihedrals within the 
molecule. This energy term is imposed in order to maintain stereochemistry at chiral 
centers, and to maintain the planarity of any planar functional groups (such as aromatic 
rings). 
( 12 6) NatomsNatoms 0.. 0 .. ~ ~4 IJ IJ EVVW = LJ LJ Bij -12- --6-
i j>i rij rij 
(B8) 
describes van der Waals potentials as Lennard-Jones functions, with a short-range 
repulsive character (accounting for steric repulsion) and longer-range attractive character 
(accounting for dispersion forces). Here, rij is the Euclidean distance between atoms i 
and j; aij is the van der Waals contact distance for atoms i and j; 0ij is a parameter defining 
the strength of van der Waals attraction between atoms i and j at their optimum distance 
from one another (relative to infinite atom separation); and the sum is computed over all 
atom pairs within the molecule. 
(B9) 
describes electrostatic potentials as Coulombic functions, which are purely attractive or 
repulsive depending on whether the atomic charges in question have opposite or equal 
signs (respectively). Here, rij is the Euclidean distance between atoms i andj; qi and ~ 
are the partial charges present on atoms i and j; and D is a dielectric constant selected to 
represent desired solution conditions. As with the van der Waals energy term, the sum is 
computed over all atom pairs within the molecule. 
Reference: 
MacKerell, A. D., Bashford, D., Bellott, M., Dunbrack, R.L., Evanseck, lD., Field, M.l, 
Fischer, S., Gao, J., Guo, H., Ha, S., Joseph-McCarthy, D., Kuchnir, L., Kuczera, K, Lau, 
F.T.K., Mattos, C., Michnick, S., Ngo, T., Nguyen, D.T., Prodhom, B., Reiher, W.E., 
Roux, B., Schlenkrich, M., Smith, J.C., Stote, R., Straub, l, Watanabe, M., Wiorkiewicz-
Kuczera, l, Yin, D. and Karplus, M. 1998. "All-atom empirical potential for molecular 
modeling and dynamics studies of proteins." Journal a/Physical Chemistry B 102: 3586-
3616. 
APPENDIX C: Background on Dictionary of Protein 
Secondary Structure (DSSP) Software 
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The Dictionary of Protein Secondary Structure (DSSP) software package identifies local 
secondary structure types adopted by amino acid residues in proteins/peptides, based on a 
combination of backbone hydrogen bond and geometry criteria. It examines seven 
possible structure types - 31O-helix, a-helix, n-helix, hydrogen-bonded B-structure, 
hydrogen-bonded turns, non-hydrogen-bonded bends, and non-hydrogen-bonded 
loop/irregular structure (which includes PPII helix structure) - and the occurrence of 
these structure types is identified as follows. 
Hydrogen bonds between amide groups of the protein/peptide backbone are first 
identified. Then, the occurrence of the five hydrogen-bonded structure types is assigned 
based on configurations of hydrogen bonds that are present within the protein/peptide 
structure. Part of this process involves identification of hydrogen bonds between the 
backbone carbonyl oxygen of residue "i" and the backbone nitrogen of residue "i+3", 
"i+4" or "i+5": 
i i+I i+2 i+3 i+4 i+5 
-N-C-C--N-C-C--N-C-C--N-C-C--N-C-C--N-C-C-
H OH OH OH OH OH 0 
:>-------------------------<: 
:>------------------------------------<: 
:>-----------------------------------------------<: 
i-i+ 3 hydrogen bond 
i-i+4 hydrogen bond 
i-i+5 hydrogen bond 
If two or more consecutive i-i+3, i-i+4 or i-i+5 hydrogen bonds are present, then the 
implicated amino acid residues are identified as forming 3 w-helix, a-helix or n-helix 
structure, respectively. If only one such hydrogen bond is present, however, then the 
implicated residues are identified as forming a hydrogen-bonded tum. 
The other type of hydrogen bonding that is examined involves pairs of hydrogen 
bonds consistent with hydrogen bond configurations found in parallel or antiparallel B-
sheet structure: 
X 
-N-C-C--N-C-C--N-C-C-
H 0 H 0 H 0 
\ / \ / 
\ / \ / 
/ \ / \ 
/ \ / \ 
H 0 H 0 H 0 
-N-C-C--N-C-C--N-C-C-
Y 
parallel (/ and \, or \ and I) 
X 
-N-C-C--N-C-C--N-C-C-
HOHOHO 
1 1 1 1 
1 1 1 1 
1 1 1 1 
1 1 1 1 
o H 0 H 0 H 
-C-C-N--C-C-N--C-C-N-
Y 
antiparallel (I or I) 
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If such hydrogen bonds are identified, then residues "X" and "Y" are identified as 
participating in hydrogen-bonded B-structure. [Notice that two possible hydrogen bond 
configurations (shown in red and green, respectively) are allowed for each case, due to 
the natural alternation of spacial orientation exhibited by successive residues in B-strands.] 
In the event that a residue is identified as potentially belonging to more than one 
of the five hydrogen-bonded structure types, then the residue's structure type is assigned 
based on the following order of structure priorities: a-helix> hydrogen-bonded B-
structure> 3 w-helix > x-helix> hydrogen-bonded turn. 
Finally, residues not exhibiting one of the five hydrogen-bonded structure types 
are assessed for the formation of non-hydrogen-bonded bends. A non-hydrogen-bonded 
bend is identified at residue i if the inter-a-carbon vectors from residue i-2 to residue i, 
and from residue i to residue i+ 2, are at an angle of at least 70° to one another: 
If a residue does not meet this criterion either, then the residue is identified as forming 
non-hydrogen-bonded loop/irregular structure. 
Reference: 
Kabsch, W. and Sander, C. 1983. "Dictionary of Protein Secondary Structure: Pattern 
Recognition of Hydrogen-Bonded and Geometrical Features." Biopolymers 22: 2577-
2637. 
115 
APPENDIX D: Background on Jonckheere k-Sample Test 
The Jonckheere k-sample test is a statistical test that permits simultaneous comparison of 
two or more samples of data, testing the null hypothesis that the samples are all equal in 
value to one another. The test compares samples based on rank order of the individual 
data values from each sample, and a single test statistic is computed for subsequent 
comparison with an appropriate critical value. The logic involved in the test is as follows. 
Let (Xl ,l, X l,2, ... , Xl,ml), ... , (Xi,l, ... , Xi,ai, .... , Xi,mi), ... , (Xk,l, ... , Xk,mk) be k samples 
of sizes m\, m2, ... , mk, randomly drawn from populations FI(X), ... , F/X), ... , Fk(X). 
Then, for all X, let 
{ l lif X .. < X .. I,W J,a; 
Pi,ai,j,qj = 0 if X X 
i,ai > j,aj 
(Dl) 
where i = 1, ... , k-l;j = i+l; Ui = 1, ... , mi; and Uj = 1, ... , mj. Then, 
(D2) 
k-J k k-J k 
S = 2~ ~Pi,j - ~ ~mimj f:f j=l+! f:f j=l+! (D3) 
For large samples, once the test statistic S is computed, a corresponding standardized 
normal statistic Z can be calculated for comparison against standard normal distribution 
tables (normal approximation): 
z = _s_ = --;======s===== 
J;; ~ {n z (2n + 3) - t mr z (2mr + 3)} 
18 ~ 
(D4) 
where n is the sum of all mr values. Alternatively, for small samples, a Student's t 
statistic can be calculated for comparison against standard Student's t tables (Student's t 
approximation, with v degrees of freedom): 
t =s v 
(v + l),uz - SZ (D5) 
where 
(D6) 
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k 
n\6n2 +15n+l0)- kmr\6mr2 +15mr +10) 
{n'(2n + 3) - ~m, '(2m, + 3) r 
and ~2 and n are defined in the same manner as with the normal approximation. 
Reference: 
Jonckheere, A.R. 1954. "A distribution-free k-sample test against ordered alternatives." 
Biometrika 41: 133-145. 
